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Introduction
Neurodegenerative diseases afflict millions of elder people in the world, with a very
high social and economic cost. These diseases are usually identified as amyloidosis,
proteopathies, protein conformational disorders or protein misfolding diseases. Among
them, Alzheimer’s disease (AD) and Parkinson’s disease (PD) are dramatically frequent [1,
2]. AD is a neurodegenerative disorder characterized by an accumulation of aberrant
folded tau protein and beta-amyloid peptides in brain [3, 4]. To date, there are no effective
therapies for AD and its cellular and molecular mechanisms are not well understood yet.
PD is a neurodegenerative movement disorder of the central nervous system, characterized
by the accumulation of misfolded α-synuclein protein in the brain [5, 6]. Nowadays, it is
well established that misfolding, misfunction and aggregation processes of proteins are
involved in the aetiology of neurodegenerative diseases, such as AD and PD, but their
specific role in the observed symptoms is still unclear [1, 2, 7]. As a consequence, protein
misfolding and aggregation are a focal area in current scientific research, with an interest
spanning from biophysics and biochemistry to medical sciences. In particular, the analysis
of aggregation processes is a key topic in soft matter and biophysics aimed at discovering
common principles which regulate supramolecular assembly. Indeed, supramolecular
aggregation is considered a general pathway in the inter-protein free energy landscape,
leading to a deep minimum assigned to fibrillar status [8]. Amyloid fibrils are ordered
elongated aggregates, characterized by a common highly organized cross-β structure [9].
Their formation is a complex hierarchical process, determined by the interconnection and
modulation of multiple mechanisms appearing at different times and length scales. These
mechanisms potentially lead to a pronounced polymorphism of intermediate and final
structures [9–11], with different biological effects [12, 13]. Depending on environmental
conditions, multiple intermediates can be formed during amyloid fibril growth. These
species may exhibit peculiar biological activity often associated to toxic effects [12–
15]. The nature and the role of toxic species are still highly debated, although the
scientific community nowadays tends to consider oligomeric species the actual effectors
of cytotoxicity [13, 16].
One of the main goals is to rationalize how the balance among different interac-
tions regulates the differences in structure, morphology and toxicity of both fibrils and
intermediate species. In this regard, the understanding of molecular mechanisms at
the basis of the aggregation processes is of utmost importance. Indeed, the detailed
comprehension of amyloid formation phenomena will bring to the rational control of
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them, potentially leading to the development of new pharmacological strategies against
amyloid related pathologies. In this context, the modulation of protein environmental
conditions and, in turn, protein-protein interactions, by the presence of small molecules,
represents a suitable route for designing potential inhibition/control strategies of their in
vivo aggregation processes.
The work described in this thesis was developed within the framework of the research
activities of Molecular Biophysics research group of the Dept. of Physics and Chemistry
of the Palermo University. In the last decades, the experimental research has been focused
on the study of in vitro aggregation processes of different proteins. The overall scientific
approach mixes studies on aggregation processes of model proteins and proteins directly
involved in neurodegenerative diseases. The first are studied to select experimental con-
ditions allowing elucidating specific features of aggregation processes. This is important,
in particular, in order to individuate common principles and driving forces regulating
supramolecular assembly. The experimental work described in this thesis was focused on
the molecular mechanisms involved in in vitro aggregation of Amyloid β peptide (Aβ)
and α-synuclein (αSN), proteins directly implicated in the AD and PD neurodegenerative
pathologies [2, 3, 5]. In physiological conditions, these two proteins are intrinsically
disordered proteins (IDPs) and, in general, their conformation and aggregation propensity
is strongly affected by their environment [17, 18]. Different protein conformations are
available at the equilibrium for a single polypeptide chain, giving to the reactive groups
the possibility of being exposed and of interacting with specific groups of small molecules.
In particular, the presence of specific molecules in solution may alter the energy landscape
profile, trapping specific conformational substates and consequently altering the balance
of multiple species in solution [19].
In the first part of the thesis it is shown how aggregation propensity of Aβ(1-40) is
strongly affected by the presence of the dye Thioflavin T (ThT) in solution. In particular,
this molecule was found to trigger fibril formation in conditions where the supramolecular
assembly would not occur in the absence of the dye. In literature, this small molecule
is widely used to analyze in situ formation of amyloid fibrils, under the hypothesis
that its presence does not affect the whole evolution of the process [20–22]. Using both
experiments and molecular dynamics simulations it was found that, as a consequence of
the ThT presence, a rigid Aβ(1-40) conformation occurs. It was highlighted that steric
and chemical properties of this small molecule are able to modulate peptide conformation
and aggregation propensity. An analogous effect was also observed for αSN. As a con-
sequence, the results suggest a thermodynamic drive toward the formation of partially
folded states, in natively unfolded proteins, by interaction of exposed residues with ThT
specific groups. Indeed, it is nowadays believed that the earliest stage of fibrillation
of IDPs is their partial folding [23]. This result could be really significant since ThT
may favour the conversion of possible toxic oligomers into less reactive amyloid fibrils.
Indeed, mature fibrils are nowadays considered as reservoirs of oligomeric species. In
this regard, a recent study showed that ThT decreases paralysis in worm models of
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Alzheimer’s disease [24]. This is an example of implications of ThT in the evolution of
amyloid related aging processes in living organisms. Importantly, the result presented
here constitutes a fundamental warning for experiments where ThT is used as normal
amyloid fluorescent probe with the assumed hypothesis of non interaction with the peptide.
Protein-solvent interaction modulated by small molecule not only affects aggregation
kinetics but also conformation, structure and stability of aggregates [25]. In the second
part of the thesis, using α-synuclein as a model, it is shown that not only fibrillation ki-
netics but also aggregates stability and morphology can be modulated by trifluoroethanol
(TFE). The aggregation process was studied and fibril stability tested in its presence.
This alcohol is known to modulate the protein secondary structure and stability on the
basis of its concentration [26, 27]. It acts changing protein solvation properties, but also
lowering the dielectric constant of the solution [25]. The experimental results draw the
attention on the dependence of native αSN and amyloid aggregates stability on their
environment. In particular, at moderate TFE concentration αSN aggregated species
are formed. These structures represent an activated state for following fibril growth,
which would not occur in the absence of TFE. The stability of the already formed αSN
fibrillar structures was found to be dependent on TFE concentration, whose changes
may lead to aggregates stabilization and clustering or to their complete dissolution. This
aspect is really important to take into account since, as already said, nowadays fibrils
are considered as reservoirs of actual cytotoxic species, which can be released if fibrils
stability is modified [13].
This thesis is divided in four chapters, the first two are introductory chapters while the
other two describe the experimental results. In Chapter 1, an overview on IPDs and the
state of the art of the amyloid aggregation kinetics is given, particularly focusing on the
literature dealing with Aβ(1-40) and αSN fibrillation. In Chapter 2, a short description of
the theoretical background of the experimental techniques used in the thesis is given. In
Chapter 3, experimental results obtained in studying the aggregation process of Aβ(1-40)
in quiescent conditions and in the presence of ThT are reported. Experimental results
are well supported by molecular dynamics simulations. In Chapter 4, the analysis of
αSN fibrillation process and fibril stability in TFE water mixtures is presented. Finally,
main results and future perspectives are discussed in Section. 4.2.
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Chapter 1
State of the art
Proteins are the most abundant class of organic macromolecules in all living organisms.
They consist of polypeptide chains of amino acids linked to each other by peptide bonds.
These macromolecules are essential for all biological processes related to life, playing a
key role in the structure and function of cellular processes such as enzymatic catalysis,
transport and storage, immunization and differentiation. Moreover, it is nowadays
established that their dysfunctions are often related to different degenerative pathologies,
e.g. type-II diabetes, the transmissible prion disorders, Parkinson’s, Alzheimer’s and
Huntington’s disease, generally referred to as amyloidosis [8, 28]. These are characterized
by extracellular or intracellular insoluble protein depositions, mainly composed by ordered
protein aggregates known as amyloid fibrils.
Due to both their crucial role in living cells and their involvement in amyloidosis,
proteins have become one of the most interesting and challenging topics in biophysical,
biochemical and biomedical research. Numerous works in this area led, among the others,
to the identification of a relatively new category of functional proteins lacking a 3-D
structure, known as intrinsically disordered proteins (IDPs) [29–32]. To them belong the
two proteins object of this study (the Aβ(1-40) peptide and αSN). Particular attention
has been paid to the comprehension of mechanisms regulating their physiological functions
[33–35] and their connections with the ones leading to amyloid fibril formation [36–40].
Several models for the mechanism of protein aggregation and, in particular, amyloid
formation have been proposed [41–43], in this second case most of them are based on
both homogeneous and heterogeneous nucleation-growth [36–38, 42, 44–47].
The first section reports an overview on IDPs with the aim of giving their main
structural characteristics, highlighting the strong influence of the environment on their
conformation and behavior. In the second section an overview on fibril formation processes,
with particular regard to nucleated mechanisms, is given. Eventually, in the third and
fourth sections the state of the art of Aβ(1-40) and the one of αSN are presented.
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1.1 Overview on intrinsically disordered proteins (IDPs)
1.1.1 Historical introduction
To date, a lot of efforts have been addressed to understand the relation between
protein conformation and functionality and the basic mechanisms leading to aggregation,
and in particular to amyloidosis. In this landscape, the last century saw the emergence
and the subsequent consolidation of the so-called Structure-Function Paradigm [48]. The
key concept is that protein folding would be a condicio sine qua non for protein func-
tionality. In other words, proteins would have to proceed from an highly disordered state
to their 3D-structure, or native state, in order to accomplish their physiological function.
For this role in functionality, protein folding has been widely investigated with the intent
to understand its regulating mechanisms [49–53]. Firstly, it was proposed that proteins
find their way to functional structure randomly searching among the enormous number
of possible configuration. This hypothesis led to the Levinthal’s Paradox [54], which
states that it would take an almost infinite time for a protein to reach its native state,
while proteins frequently fold in less than 1 second. To explain how a polypeptide chain
can fold in a finite time, in 1973 Anfinsen suggested that “it is necessary to postulate the
existence of a limited number of allowable initiating events in the folding process” [55].
Starting from this consideration, the apparent paradox was definitively overcame in 1980s
and 1990s with the introduction of a statistical approach to the energetics of protein
conformation landscape [56–58]. On the basis of this view, the different conformations,
which a protein can assume, are not all equally likely, but the probability of a polypeptide
chain to explore the different conformational states on the energetic landscape surface
depends on its amino acidic sequence [57]. The native state of a protein is reached
through kinetic pathways on a funnelled energy landscape of intramolecular contacts (see
Fig. 1.1-Left) [59–62]. Such pathways drive the proteins trough relative minima, in such
a way that the protein explores a reduced number of conformations. On the basis of
this picture, protein aggregation and consequently protein misfolding diseases, would be
caused by abnormal folding, or misfolding, as well as unfolding, which lead proteins to
experience partially folded states [1, 8]. Indeed, the correct folding towards the native
state relegates the most hydrophobic amino acids into the core, hiding them from the
solvent. As a consequence, an incorrect folding or a partially unfolding, leading to the
exposure of such amino acids, enhances protein aggregation propensity.
Despite the large amount of experimental and computational works confirming the
picture drawn above, in the last two decades, the scientific community had to reappraise
the relationship between proteins in disordered states and amyloidosis and completely
dismiss the concept of Structure-Function Paradigm as a general rule [17, 31, 63]. Indeed,
it has been demonstrated that not only several globular proteins possess disordered
regions necessary for their function [64, 65], but also that biologically active proteins
lacking of a 3D-structure along the whole chain are actually very common in nature
[18, 33, 65, 66]. In a recent review Dunker et al. [67] identified the expression Intrinsically
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Figure 1.1: Left: an example of funnelled energy landscape describing the process of folding for
a globular protein containing 27 residues. Rows indicate the average path (in yellow) and a range
of two standard deviations around it (in red and green). Adapted from the original paper [61].
Right: an example of IDPs energy landscape showing multiple shallow local minima corresponding
to the comparable more stable conformations. Adapted from the original paper [32].
Disordered Proteins (IDPs) as the most meaningful to indicate proteins from this second
group.
1.1.2 Structural and conformational fingerprints of IDPs
The choose of the name IDPs to indicate proteins without a well folded conformation
in physiological conditions derives from two characteristics that distinguish them. Indeed,
the word “disordered” indicates the major characteristic common to all the IDPs: the
almost completely, or even completely, lack of a rigid tertiary structure, typical of
globular proteins [29]. The word “intrinsically” indicates that the conformational disorder
represents an inherent property of these proteins, which is encoded in their amino acidic
sequence [30, 65, 68].
More in detail, in 2002 Uversky demonstrated that hydrodynamic volumes of IDPs
show comparable values to that of globular proteins with the same chain length in their
premolten globule or denatured conformational states [18]. Moreover, several works
shown that IDPs are characterized by a great flexibility and a low content in secondary
structure [69–71]. For example, it has been established that the High-Mobility-Group
Chromosomal Protein HMG 17 almost completely lacks secondary structure [69]; bone
sialoprotein (BSP) and osteopontin (OPN) explore an ensemble of conformations, both
being completely unstructured in solution [70]; the NAC region of αSN (residues 61-95)
has a larger hydrodynamic radius than globular protein of similar molecular weight
and it is characterized by the absence of significant secondary structure content [72].
In summary, in vitro and in physiological conditions, IDPs are mainly characterized
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Figure 1.2: Comparisons of amino acid compositions for disordered (a) and globular (b) proteins.
For each residue the amino acid mole fractions (Rai −Rbi )/Rbi are reported as determined by X-ray
diffraction, NMR and CD measurements. Adapted from the original paper [30].
by i) a large hydrodynamic radius [18, 72, 73], ii) a low content of ordered secondary
structure [69–72] and iii) an high intramolecular flexibility [29, 70, 71].
To give an example of what is meant by “encoded in the amino acid sequence”, the
amino acid composition of different protein segments, identified as disordered by x-ray
diffraction, nuclear magnetic resonance or circular dichroism, respect to the one of ordered
proteins is reported in Fig. 1.2 [30]. The amino acid mole fractions (Rai −Rbi )/Rbi , which
compare pairs of disordered (a) and globular (b) proteins sets, are reported for each
amino acid i. As shown, IDPs are depleted in aromatic (Trp, Tyr, Phe) and hydrophobic
(Iso, Val) residues, and enriched in structure-breaking (Pro ang Gly) and charged residues
(Lys, Glu). In particular, a combination of low overall hydrophobicity and large net
charge represent a unique structural feature of IDPs [29, 30]. This is evident from the
charge-hydrophobicity phase space shown in Fig.3, where IDPs are localized in a specific
region, aside the one for globular proteins. Only α-synuclein and other two proteins
(green, yellow and white circles in Fig.3) do not fit the general trend shown by the other
88 analysed IDPs [29].
These IDPs structural characteristics are really important to consider in order to
establish if a protein belongs to IDPs. Indeed, when recombinant proteins are used, the
question could arise if the lack of rigid melted tertiary structure observed in vitro, in
physiological conditions, is an artifact due to protein purification, or if it is indeed a
viable reproduction of their in vivo behavior. In this regard, computational approaches
looking over the amino acidic sequence represent valuable tools [74]. Indeed, strictly
speaking, in the absence of direct in vivo evidences, assignment of a protein to the
family of IDPs can only be done when its sequence (see Fig. 1.2) and physico-chemical
properties (see Fig. 1.3) both converge to show that protein is intrinsically disordered
in physiological conditions [74]. Obviously, this is only a general rule, which can be
applied in the absence of in vivo observations. For example, in the case α-synuclein,
although it is localized outside the IDPs region in Fig. 1.3, in-cell NMR measurements
demonstrated that in E. coli cytosol α-synuclein presents the same characteristics as
the disordered monomeric form observed in vitro in aqueous solutions [17] (see also
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Figure 1.3: Mean net charge as a function of mean hydrophobicity for 275 monomeric ordered
proteins (blue squares) and 88 disordered proteins (red circles). Green, yellow and white circles
refer to α-synuclein, negative factor (NEF) and helix destabilizing protein, respectively. The green
triangle refers to the last 44 residues in the C-terminal region of α-synuclein (see Section 1.4).
Adapted from the original paper [29].
Section 1.4). Beside these structural fingerprints, IDPs are also characterized by a
dynamic conformation. Indeed, in the last two decades, different experimental techniques
[e.g. nuclear magnetic resonance (NMR), small angle scattering (SAS), gel-filtration,
dynamic light scattering (DLS), circular dichroism (CD)], revealed that IDPs do not
represent a homogeneous class, but an ensemble of different conformations [70, 75, 76].
Indeed, in contrast to globular proteins, in vitro and in physiological conditions, they
exhibit a relatively flat energy landscape (see Fig. 1.1-Right), enabling them to sample a
variety of conformations [32, 77]. In particular, IDPs can be found in any of these three
conformations: molten globule (MG), premolten globule (PMG) and random-coil-like
(RC-like) structures [17, 78, 79]. With respect to their globular state, proteins in the
MG state retain almost all the secondary structure, while their hydrodynamic volume
increases of about 1.5 times, also accompanied by a considerable increasing of affinity
to hydrophobic fluorescent probes (e.g. 8-anilinonaphthalene-1-sulfonate, ANS). In the
case of PMG state the secondary structure is reduced to about 50%, the hydrodynamic
volume increases of about three times and the affinity to hydrophobic dyes is still higher,
although lower than in the MG state. IDPs in the random coil state are devoid of any
secondary structure and they completely lose the affinity to hydrophobic probes, while
the hydrodynamic volume becomes even twelve times larger [29].
The observation that in IDPs biological function can arise from any of the three states
MG, PMG, RC-like, or from transitions between them [79, 80], led to the replacement of
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Figure 1.4: Schematic representation of Protein quartet model : protein function can arise from
any of the four indicated states or from the transition between two of them. Adapted from the
original paper [17].
the above cited Structure-Function Paradigm with The Protein Quartet Model reported
in Fig. 1.4 [17, 29]. According to this model, protein function can arise from globular
proteins as well as from IDPs and, in particular, from any of the four states globular, MG,
PMG or RC-like, or as result of a transition between two of them. For example, it has
been shown that the High-Mobility-Group Chromosomal Protein HMG 17 [69] and heat
shock transcription factors of Kluyveromyces lactis and Saccharomyces cerevisiae [81]
partially fold upon interaction with DNA, their N- terminal regions remaining disordered;
4E binding proteins fold only in their central region upon interaction with limiting,
proto-oncogenic initiation factor eIF4E, the remaining being in its disordered state [82].
1.1.3 Influence of the environment on IDPs conformation
It has been established that IDPs perform several specific functions that can be
divided in molecular assembly and recognition, protein modification and entropic chain
activities. In order to accomplish these functions, IDPs often undergo in vivo disorder-to-
order transitions as sketched in Fig.4, although sometimes they remain in their disordered
conformation [17, 29, 79, 80]. Indeed, the main peculiarity of these proteins is their
huge plasticity. IDPs are able to interact with different partners, modulating their
conformation on the basis of the particular function. Several observations reveal IDPs
folding before, during or after interaction with partners. This is often only a partial
folding, involving only part of the IDPs chain [69, 81, 82].
To date, different scientists have posed the question if the induction of folding in
in vivo environment is essentially a process driven by an excluded volume effect due
to crowding, or if it is a more complex process, due to specific interactions and to
environmental factors such as, for example, pH, ionic strength or temperature. To answer
this question in vitro experimental studies have been carried out using concentrated
solutions of model “crowding agents”, such as polyethylene glycol, dextran, Ficoll or
inert proteins [83, 84]. Not all these works revealed significant conformational change
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attributable to crowding [84–87]. Based on these observations it has been concluded that
molecular crowding effects are not necessarily sufficient to induce ordered structure in
IDPs [17, 84].
In this landscape, other in vitro studies showed that IDPs conformations are strongly
influenced by the environment. For example, the disorder-to-order, partial or total,
transitions upon binding to metal ions [88–93], upon interaction with membranes or
liposoms [94–97] or for the addition of co-solvents to the solution [26, 27, 98, 99] have
been observed [17, 18]. In this regard, it has been shown that binding of metal ions
Cd2+ and Zn2+ induces metallothioneins folding [90]; the peptide R2, derived from
tau protein (residues 287-304) (showing a CD spectrum typical of partially disordered
secondary structures in aqueous solutions), assumes a monomeric α-helical conformation
upon binding with Cu2+ [91]; binding of the metal ion Zn2+ leads the unstructured
peptide Aβ(1-16) to assume a compact conformation [92]; α-synuclein assumes a molten-
globule conformation upon binding of copper or iron, resulting in an enhanced fibrillation
propensity [88, 89]. Moreover, it folds in α-helical conformations upon interaction
with membranes and it is able to modulate its secondary structure in the presence of
simple and fluorinates alcohols [26, 27]; one of the tate embryogenesis abundant (LEA)
proteins, the protein LEA18, partially folds in β-sheet structures in the presence of
negatively charged liposomes [97]. The intrinsically disordered protein Methyl CpG
binding protein 2 (MeCP2) undergoes a partially coil-to-helix transition in the presence of
trifluoroethanol [98]. Moreover, interaction of IDPs with small molecules has resulted in a
modified functionality or aggregation propensity [100]. This is the case, for example, of the
oncoprotein c-Myc whose transcriptional activity can be inhibited upon interaction with
the small molecule 10058-F4 [101]; while the inositol stereoisomers epi- and shyllo-inositol
stabilize Aβ(1-42) oligomers with a β-sheet structure Aβ peptides [102].
Solution conditions as temperature, pH, ionic strength or dielectric constant have
to be taken into account. Indeed, changing these factors can lead to a partial or total
folding, or a variation in the secondary structure content [26, 27, 103, 104]. This is due
to the fact that, on increasing temperature, the strength of hydrophobic interactions
can increase [105]. In contrast, variations in pH change the large net charge present at
neutral pH and consequently modify the charge/charge intramolecular repulsion, thus
possibly shifting the conformational ensemble toward more compact states [77]. For
example, a temperature-induced folding was found for caldesmon 636-771 fragments [31],
αS-casein [106], and several other IDPs [74, 77]. In 2010 Kjaergaard and coworkers showed
that the tree IDPs ACTR, NHE1, and Spd1 change their secondary structure as a function
of temperature [103]. In 2001 Uversky and coworkers showed that either a decrease in pH
or an increase in temperature induce αSN partial folding, with a significant amount of
secondary structure [104]. Besides αSN, several other IDPs show structural parameters
depending on pH, such as protymosin α, pig calpastatin domain I, histidine rich protein
II [74]. All the peculiarities above reported, reveal a strong IDPs dependence on their
environment, highlighting a really complex scenario. This is reflected in IDPs energetic
landscapes describing intramolecular interactions, which are rough surfaces lacking of
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a deep global minimum typical of globular proteins (see Fig. 1.1-Right). This shallow
roughness reflects the high conformational dynamics and flexibility typical of IDPs, and
also provide a clear description of how an IDP can specifically interact with many ligands
of different nature and fold differently as a result of these interactions. Indeed, this type
of energy landscape is exceptionally sensitive to local environment, much more than the
relatively robust funnel-like energy landscape of an ordered protein [77]. Free energy
minima can be made deeper or barriers higher by modifying some environmental factors,
explaining the ability of an IDP to fold differently depending on the environmental
conditions. Moreover, it is also necessary to keep in mind that IDPs are heterogeneous
systems which, in general, can not be described by only one landscape as the one reported
in Fig. 1.1-Right. To be more precise, a single protein might be described by a set of these
landscapes one for each different part, each replying to the environmental changes in its
own way, which can be dependent, semi-dependent or independent on the others [77].
This heterogeneity of the energy landscape defines the ability of IDPs to form fuzzy
complexes, where significant part of a protein preserves its intrinsically disordered state
even in the bound conformation [77].
1.2 Amyloid fibrils
Protein dysfunctions are related with several human diseases, such as cancer, cardio-
vascular diseases, neurodegenerative diseases and diabetes. Often these pathologies are
characterized by extracellular or intracellular amyloid fibrils deposition, which accumulate
in a variety of organs and tissues. These are insoluble protein aggregates characterized
by an high ordered β-sheet structure [9]. More than 20 proteins are known to be
involved in these human diseases referred as amyloidoses [7]. These include, for example,
immunoglobulins in primary systemic amyloidosis and multiple myeloma, amylin in the
diabetic pancreas, α-synuclein in Parkinson’s disease and small soluble peptide such as
the amyloid β-peptide (Aβ) in Alzheimer’s disease. However it is nowadays believed that
the propensity to aggregate forming amyloid fibrils is a general property of all the amino
acidic chains [7]. Indeed, a great number of not-amyloidogenic proteins have been shown
to form amyloid fibrils.
During the last decades, several works showed that amyloidosis are related to globular
proteins as well as IDPs dysfunctions. However, molecular mechanisms of fibrillation
of IDPs and of ordered proteins are different. Contrary to what found for globular
proteins, in order to populate disordered conformations to accomplish their functions,
IDPs are poorer in hydrophobic amino acids content [17, 29, 30]. The exposure to the
solvent of any amino acids, being the native functional condition of IDPs, does not lead
to aggregation. In this case the cause for an increased aggregation propensity is the
formation of non-native more compact conformations. In other words, if for ordered
proteins the first critical step in fibrillogenesis is the partial unfolding [8], the earliest
stage of fibrillation of IDPs is their partial folding [23].
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Fibrillation and, more in general, protein aggregation are complex processes in-
volving protein-protein interactions mediated by the solvent. They depend on envi-
ronmental condition such as pH, temperature, ionic strength, cosolvents, presence of
metals [26, 40, 41, 107]. In general, aggregation processes are characterized by multiple
interconnected mechanisms. Among them, the appearance of oligomers, on-pathways
or off-pathways for fibril formation, is of particular interest. Until the end of 1990s
data available and genetics of amyloid diseases supported a quite general consensus that
amyloid fibrils are the basic toxic species in amyloid plaques. However, at the end of
the 1990s the attention shifted to the cytotoxicity of amyloid fibril precursors, notably
amyloid oligomers and protofibrils [108]. Data also started to appear indicating that
neuronal synapses were the main target of cytotoxicity [109]. Soon after, in 2002, data
were reported suggesting for the first time that cytotoxicity is a generic property of
amyloid oligomers [110] associated with a shared “toxic” fold [111]. The detrimental role
of oligomers is presently supported by a large number of data on many in vivo and in
vitro amyloidogenic proteins indicating a direct cytotoxic effect of amyloid aggregates [1].
The cytotoxicity of pre-fibrillar amyloid assemblies has been confirmed for all proteins and
peptides associated with amyloid diseases, including Aβ peptides, α-synuclein, amylin,
β2-microglobulin, transthyretin and others [112, 113]. At the present, the pivotal role of
amyloid oligomers as key players of amyloid cytotoxicity is widely recognized. Nowadays,
fibrils are considered as reservoirs of oligomeric species. As a consequence, to date most
of the efforts of the scientific community have been addressed to the comprehension of
mechanisms regulating amyloid fibril formation [37, 47, 114, 115], and to the detection of
possible intermediate species and interconnected aggregation pathways leading to fibril
production [22, 116]. Indeed, a deep understanding of such processes is fundamental in
order to develop effective therapeutic strategies. In particular, several efforts have been
addressed to the formulation of aggregation models able to describe fibrillation processes
at a molecular level [14, 41–43, 117].
In general, supra-molecular association leading to fibril formation involves conforma-
tional changes, which drive the protein from its native conformation (globular or disor-
dered) to ordered fibril structures. These conformational changes can take place before or
during supramolecular assembly [40, 118, 119]. Although some proteins seem to assemble
through entirely non-nucleated processes [40, 116, 120], the fibrillation mechanisms of
most proteins can be well described by means of models based on nucleation-growth,
both homogeneous and heterogeneous [37, 38, 44, 121].They can include initial micelle
formation [122], changes in protein conformation [28, 104, 123], and filament-filament
association [124]. In particular Aβ peptides and αSN, objects of this study, are reported
to form amyloid fibrils by means of nucleated processes [41, 104, 125, 126]. A brief
description of such aggregation mechanisms is reported in the following.
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1.2.1 Nucleation mechanisms of aggregation
Nucleation processes are first-order phase transitions including crystallization, self-
organization of ferroelectric domains and nanofilms, formation of micellar solutions,
formation and growth of diamonds from vitreous carbon, and, as already said, of amyloid
fibril from monomers or oligomers [127]. These processes can be divided in two categories:
primary nucleation (or homogeneous nucleation) and secondary nucleation [37, 38, 127].
Fig. 1.5 shows a schematic representation illustrating the microscopic mechanisms of
nucleated mechanisms for the particular case of polymerization, to which this section
refers. Homogeneous nucleation is characterized by two main steps, a nucleation phase
and a growth phase. During the nucleation phase the system is in a metastable state, the
unfavorable formation of oligomeric species proceeds with the same probability of critical
nucleus formation in any given volume or surface element (see Fig. 1.5-A) [37, 47, 127]. All
oligomers shorter than a critical size, defining the so called nucleus nc, are unstable. The
growth phase only starts when the population of nuclei is enriched. After this step, unit
addition to the ends of polymers takes place contemporary with the first phase. This step
is characterized by dissociation constants much smaller than association ones [37, 128].
Together with homogeneous nucleation processes, secondary nucleation mechanisms can
be identified, either heterogeneous nucleation or fragmentation or branching [37, 47],
indicated by C), D) and E) in Fig. 1.5, respectively. Heterogeneous nucleation consists in
the formation of aggregation nuclei directly on the polymer surface (surface-catalysed
nucleation) [37, 47]; fragmentation consists in breaking of polymeric chains with the
subsequent formation of new ends available for the addition of monomers; branching is
the addition of a unit or an oligomer on filament surface leading to polymeric elongation
from it. The three mechanisms lead to a great enhancement of the aggregation rate in
comparison to the one characterizing primary nucleation.
Different models have been formulated to describe such processes. The classical theory
of nucleated polymerization, formulated by Oosawa and coworkers in the 1960s, describes
the growth of filamentous structures formed through homogeneous nucleation [129]. It
predicts a quadratic time dependence of mass concentration of polymers, for t−→0.
This model applies to the case of nuclei in thermodynamic equilibrium with monomeric
population (see Fig. 1.5-A), and was successful in describing a variety of characteristics of
the polymerisation of actin and tubulin. When nuclei are formed by subsequently monomer
addition, in the so called downhill polymerization model, the mass concentration of
polymers, for t−→0, shows a power behaviour (see Fig. 1.5-B) [130]. This is characterized
by a biphasic behavior: a first phase during which polymer mass does not apparently
increase, known as lag-phase, followed by an abrupt growth. In 1980s the Oosawa’s theory
has been generalized by Eaton and Ferrone to include secondary nucleation processes,
such as surface-catalyzed nucleation [36, 37] (see Fig. 1.5-C), and by Wegner in order to
include fragmentation processes into the growth model for actin filaments (see Fig. 1.5-
D) [131]. In these cases an exponential behavior is found for t−→0 [38], leading to the
observation of biphasic behavior: a lag-phase and a growth phase. Recently, a more
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Figure 1.5: Schematic representation illustrating the microscopic mechanisms of nucleation
processes. Homogeneous nucleation during its first phase (sketched on the left sides of A and B)
leads to the creation of nuclei of length nc from soluble units. Nuclei can be in thermodynamic
(very unfavorable) equilibrium with the units (A), or created by subsequently unit addition.
From them, filaments growth from both ends. Secondary nucleation mechanisms (sketched on
the left sides of C, D and E) lead to the creation of new fibril ends from pre-existing polymers,
through nucleation on their surfaces (C), fragmentation (D) or branching (E). Graphs on the
right sides show the polymer mass growth behavior during the early times of the kinetics (t−→0).
Equilibrium nucleation shows a quadratic time dependence [129]; downhill polymerization a power
low [130]; secondary nucleation mechanisms an exponential behavior [37]. Adapted from the
original paper [38].
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Figure 1.6: Nucleated polymerisation in the presence of an increasing quantity of seed material
of a fixed average length (5000 monomers per seed) added at the beginning of the reaction. The
seed concentrations given as a fraction of the total concentration of monomer present are: 0, 0.01,
0.04, 0.1, 0.2, 0.5 (right to left). Adapted from the original paper [134].
complete description theory of nucleation processes, including primary and heterogeneous
nucleation and fragmentation , has been reported by Knoweles’ research group in a set of
exhaustive works [47], [132], [133], [134]. All the models just mentioned describe the
process of nucleation from a kinetic point of view, taking the moves from the master
equations. Besides these, it is worth to mention that, more recently, Di Michele and
coworkers published a notable work in which they develop a theoretical model for fibril
formation [115]. This model is based on the mathematical description of protein-protein
interactions, from a physical point of view. It is able to reproduce the exponential growth
due to self-catalytic conversion of monomers towards aggregation-prone conformations in
the presence of pre-existing aggregates.
In in vitro experiments, during fibril formation starting from soluble monomers,
primary and secondary nucleated mechanisms often coexist. Aggregation processes
controlled by secondary mechanisms are intrinsically unrepeatable. They are characterized
by stochasticity, which is experimentally revealed in a random duration of the lag-
phase [46, 125, 135]. Its average value and standard deviation are function of protein
concentration, both lowering as protein concentration increases [45, 46, 125, 126, 135].
Interestingly, in certain cases, in these processes the prevalence of a mechanism
rather than another can be inferred by the qualitative behavior of kinetics curves. A
remarkable example is given by the case in which the aggregation process takes place
in the presence of preformed aggregates, usually referred as seeds. If the process is
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essentially governed by homogeneous nucleation and elongation from ends, secondary
nucleation mechanisms being negligible, the lag-phase reduces as seeds concentration
is raised (see Fig. 1.6) [42, 134, 136]. The extreme case is represented by the concave
growth in Fig. 1.6 (cyan dashed line), where no lag-phase is observed. The reaction
kinetics is characterized by an exponential approach to equilibrium [42, 134]. In this case
the polymeric mass only increases for the addition of monomers to polymer ends, and
the number of polymers remain constant along the whole reaction since no nucleation
occurs [42, 134]. This observation will be taken into account in Chapter 3. Indeed, the
ThT fluorescence signal as a function of time of Aβ(1-40) kinetics presents a concave
behaviour similar to that shown by the cyan dashed line in Fig. 1.6, without a lag-phase.
This is compatible with a pre-seeded nucleation process with the elongation from ends
more effective than primary nucleation [134].
1.2.2 Amyloid fibril structure
Mature amyloid fibrils are ordered protein aggregates which are made by a variable
number of protofilaments (see Fig. 1.7). These are characterized by a well defined
structure, usually referred as cross-β, whose main features are independent of the amino
acidic chain from which fibrils originate. Fig. 1.8) shows a schematic representation of
a protofilament. It consists in the repetition of fundamental units extending along a
preferential direction, the fibril axis. These units are β-strands arranged at a distance
(main chain spacing) of approximately 10 A˚, bounded together by means of hydrogen
bonds in such a way that they form β-sheets. The cross-β structure protofilament
consists in two juxtaposed β-sheets, at a distance varying in the range 8.8-14.6 A˚, usually
indicated with the term side chain spacing, depending on the particular fibril [9].
In general, mature fibrils can differ for side chain spacing, number and arrangement of
protofilaments and in the arrangement of the side chain within the cross-β structure (see
Fig. 1.7) [9, 137, 138]. Such variable arrangement is usually indicated with polymorphism
or microscopic polymorphism. Polymorphism is not only related to fibrils grown from
different amino acidic chains, but it can also arise from the same protein, in samples
differing in chemico-physical parameters as well as in the same sample [9]. Interestingly,
structures with different morphologies can show different degree of cytotoxicity [10]. In
this regard, a notable study has been published in 2005 by Petkova et al. The authors
studied two identical samples of Aβ(1-40), incubating them in quiescent conditions
or in the presence of mechanical agitation. They found that fibrils fibrils from these
two samples show different molecular and/or secondary structures, and morphologies,
has been shown to propagate from mother to daughter samples in seeded experiments
[10, 139]. Recent studies have point out that, beside microscopic fibril polymorphism,
macroscopic polymorphism also exist. Indeed, fibrils can be arranged in different 3D
packing structures called superstructures, although maintaining their cross-β structure.
In a recent and generalized work Fodera´ et al. demonstrated that the formation of any
kind of aggregates superstructures, and in particular fibril superstructures, is driven
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Figure 1.7: Schematic representation of different amyloid fibril morphologies which differ in the
number, relative orientation or structure of the underlying protofilaments. Adapted from the
original paper [9].
by electrostatic protein-protein interactions [114]. Branched, twisted or straight fibrils,
bundles of fibrils, dense network of filaments and spherulites are all example of fibril
superstructures, with characteristic sizes in the range of several micrometers [11]. Fig. 1.9
shows an environmental scanning electron microscopy imagine of a fractured spherulite,
grown from an insulin sample at pH 1.8 [11]. These kind of structures consist in a dense
Figure 1.8: A: representation of the frontal view of a β-sheet, consisting of β-strands, whose
mutual distance is usually referred as main chain spacing. The arrow indicate the direction of
the fibril axis. B: representation of the top view of two juxtaposed β-sheets, whose distance is
usually indicated with side chain spacing. Adapted from the original paper [9].
core, referred as precursor, and an external shell made of spherical arranged fibrils. Since
they have been found to coexist in solution with free fibrils, it is still not clear if they
1.3. β-Amyloid peptide 1-40 19
Figure 1.9: environmental scanning electron microscopy imagine of a spherulite grown from an
insulin sample at pH 1.8. Adapted from the original paper [11].
form from monomers or from pre-formed fibrils, which subsequently arrange in a spherical
shape around precursors [11]. Spherulites have been shown to form from several globular
proteins, under destabilizing conditions, at low pH values, distant from the protein
isoelectric point [11, 140, 141]. It is worth to mention that, in 2010 Exley et al. showed
for the first time the in vitro formation of Aβ(1-40) spherulites in near-physiological
conditions [142]. These kind of structures have been found in vivo within amyloid plaques
of Alzheimer’s disease. Besides, only recently, also αSN spherulites have been observed
in vivo [143]. However, they have never been observed in in vitro aggregation processes.
1.3 β-Amyloid peptide 1-40
The self-assembly of beta amyloid peptide 1-40 into fibrillar structures is closely
related to Alzheimer’s disease development. The 40 residues peptide (Aβ(1-40)) is one of
three peptides naturally occurring from the proteolitic cleavage of the amyloid precursor
protein (APP) [35]. Two enzymes, β-secretase and γ-secretase, act in sequence cutting
the transmembrane protein APP. On the basis of cleavage position along the polypeptide
chain, three different peptides can be released in the extracellular space: the beta amyloid
peptides 1-39, 1-40, 1-42. Although their physiological role has yet to be clarified, they
seems involved in the regulation of synaptic activity [35]. Among these three peptides,
the Aβ(1-40) is the most abundant species in human brain. Its primary structure of 40
amino acids is given by:
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV
Aβ(1-40) peptide belongs to IDPs; indeed, in solution at physiological pH it is
unstructured, presenting a CD spectrum typical of random coil conformation with a
deep minimum at about 198 nm [118]. It exists as an ensemble of rapidly converting,
nearly isoenergetic, conformations whose population is dependent on the physico-chemical
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properties of the solution.
Depending on solution conditions Aβ(1-40) can also form amlyloid fibrils in vitro,
giving the opportunity for a more thorough investigation of the aggregation kinetics.
Several reports indicate that the in vitro Aβ(1-40) aggregation process proceeds via
nucleated mechanisms characterized by multiple pathways involving a number of inter-
mediate species eventually leading to polymorphic structures [9]. These mechanism are
characterized by a nucleation phase, followed by a growth phase, consisting in the addition
of monomers to filament ends. Different studies suggest a “dock and lock” mechanism
regulating the second phase. On the basis of this mechanism monomers initially bind to
(or dock onto) the exposed regions of a fibril in a reversible manner. The docking step is
then followed by an irreversible re-organization of the fibril surface, which generates the
most optimal surface area for further fibril growth [115, 119].
It has been found that at low pH Aβ(1-40) fibrillation occurs by means of a nucle-
ated process in which nuclei consist of peptide micelles and fibril elongation occurs by
irreversible binding of Aβ monomers to the fibril ends [122, 144].
At physiological pH, in some experimental conditions, the formation of oligomeric
transient α-helix species has been reported to represent a key step in the fibrillogenesis
of 18 Aβ peptides, among which Aβ(1-40) [118, 145]. The most rapid formation of the
partially helical intermediate occurs in the pH regime in which the β-carboxyl group of
Asp23 is ionized and the imidazole ring of His13 is protonated, suggesting a significant
role exerted by these two residues on the kinetics of Aβ fibrillogenesis. The formation
of helical intermediates was also investigated by trifluoroethanol (TFE) addition to
the solution. In particular, low concentrations of TFE, favouring the conversion to
conformations containing a certain amount of α-helical secondary structure, enhance the
fibrillation rate; while concentration higher than 20% v/v leads to α-helix stabilization
hindering, as a consequence, fibril production [145]. However, the direct conversion from
random coil to β-sheet structures has been observed as well [145].
It is worth to mention that, in very similar conditions to that employed in the
experimental work of this thesis, the Aβ(1-40) peptide fibrillation process has been
reported to occur by means of an heterogeneous nucleation [125]. The main difference
between the experimental conditions employed in this study and those reported in this
thesis consists in the different volumes of incubation. In particular, Hortschansky and
co-workers employed volumes of about 200 µl, while in this work volumes of about 750 µl
were used.
Different studies emphasize the importance of the dynamic interplay between Aβ
monomer conformation and oligomerization state in controlling fibrillogenesis kinetics.
In specific conditions, aggregation-prone conformations can be favored, also involving
the appearance of oligomeric species in solution, causing the onset of supramolecular
assembly that leads to fibril formation [118, 145]. In this regard, in a recent study,
a chemical kinetic based approach was used in order to connect the measurements of
macroscopic observables to microscopic mechanisms, in Aβ(1-42) amyloid fibril and
oligomers formation [126]. Such an approach aimed at gaining some insights into the
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multiple events involved in the formation of such supramolecular assembly. The authors
of this work showed that cytotoxic oligomers form once a critical concentration of fibrils
has reached. The formation of these species occurs by means of secondary nucleation
mechanisms, in a fibril-catalysed manner [126].
1.4 α-Synuclein
Wild type α-synuclein (αSN) belongs to a family of proteins highly expressed in
neurons usually indicated as synucleins. It is mainly localized at presynaptic nerve
terminals and is almost absent from peripheral tissues [146]. It was first identified in 1993
as the precursor protein for the non-β amyloid component (NAC) found in Alzheimer’s
disease plaques. It has been associated with Parkinson’s disease (PD) since 1997, when its
mutation, A53T, was identified to cause early-onset autosomal dominant PD. αSN is the
major component of Lewy bodies and Lewy neuritis [5, 6]. These consist of proteinaceous
deposits, which are the hallmarks of PD [147]. Nowadays it is largely accepted that αSN
aggregation and interaction with membranes are involved in the PD pathogenesis [148].
The primary sequence of the human αSN consists of 140 amino acids, which can be
divided into three regions (see Fig. 1.10): the amphipathic repeat or N-terminal region;
the non Aβ component (NAC) region; and the acidic or C-terminal region [149]. The first
one, consisting of the first 60 amino acids that contain 4-11-residue imperfect repeats
with a conserved KTKEGV motif, is characterized by a high inclination to form α-helix
structures upon interaction with membranes. The NAC region is formed by residues
61-95 and is the second major component of amyloid plaques typical of Alzheimer’s
disease brains. It seems also to be directly involved in the pathologic aggregation of αSN.
The last one (residues 96-140) is rich in acidic residues and prolines and is characterized
by high net mean charge and low mean hydrophobicity (see the green triangle in Fig. 1.3),
which induce a disordered structure in physiological conditions.
αSN is characterized by a disordered conformation in vitro and in physiological
conditions. For example, in aqueous solutions at neutral pH, αSN leads to CD, FTIR
and SAXS signals typical of a polypeptide chain lacking a tertiary structure and with
low content of secondary structure [2]. However, it assumes a conformation slightly more
compact than expected for a random coil [146].
It is nowadays well known that either a decrease in pH or an increase in temperature
transforms the αSN ensemble of disordered native states in an ensemble containing a
certain percentage of partially folded states, with a significant amount of secondary
structure [2, 104].
Despite the great number of in vitro experimental works revealing a monomeric
disordered structure, physicochemical properties of αSN differ from that of the other
IDPs shown in Fig. 1.3. Indeed, it is characterized by lower mean net charge and higher
hydrophobicity. As a consequence, according to what said previously (see 1.1), these
evidences would not be sufficient to assign the protein to the class of IDPs. In this last
years, this aspect has been investigate by several studies resulting in ambiguous evidences.
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Figure 1.10: α-Synuclein primary sequence. Adapted from the original paper [149].
In 2011 it had been suggested that αSN could form a tetramer in vivo and that the
disordered highlighted behaviour is not an intrinsic protein property but originates from
employed purification protocols [150, 151]. However, this remains a minority position,
contradicted by a vast literature on the properties of natively unfolded αSN. Among them,
it has been recently demonstrated that, at least within E. coli cytosol, αSN populates a
highly dynamic state, with the same characteristics as the monomeric form observed in
aqueous solutions [152]. These contradictory findings, combined with the fact that αSN
is extremely sensitive to its environment, have led to the emergence of the concept of the
protein chameleon. According to it, αSN can modulate its structural behaviour on the
basis of the surroundings. Its conformation can span from disordered monomeric species
or a more compact state to soluble oligomers with different morphologies and cytotoxicity.
In this landscape, α-helical tetramer is likely to be just one of many potential structures
realized under the umbrella of the dynamic conformational ensemble [2], due, for example,
to the interaction with biological membranes.
αSN fibril formation occurs by means of a nucleated processes, which are characterized
by a rate-limiting step, usually called lag phase, due to the formation of nuclei, and a
growth phase, during which fibrils elongate by means of monomer addition to the filament
ends (see 1.2).
Being αSN an intrinsically disordered protein, its aggregation propensity is highly
increased by the formation of partially folded conformations. This has been point out
in 2001 by Uversky and coworkers who shown how a decrease in pH or an increase
in temperature, leading to partially folded conformations, enhances αSN fibrillation
propensity [104]. In this work the authors proposed the scheme reported in Fig. 1.11 for
αSN fibrillation. On the basis of this model, the formation of αSN nuclei takes place
starting from a population of αSN partially folded states. Polymer elongation could
involve the addition to their ends of disordered monomers as well as of partially folded
intermediates.
In the light of this study, in 2009 Morris et al. confirmed the model suggested by
Uversky in 2001 demonstrating that αSN fibrillation can be described by means of the
so called Finke-Watzky 2-step model of nucleation and autocatalytic growth.
Further confirming the role played by αSN folding in fibrillation, recently, it has
been shown that αSN folding in dimeric species enhances the production of cytotoxic
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Figure 1.11: Representation of α-synuclein fibrillation model proposed by Uversky et al. in 2001.
The nucleation process takes place from partially folded states, which lead to nuclei formation.
Elongation of polymers could involve the addition to their ends of disordered monomers as well
as of partially folded monomers. Adapted from the original paper [104].
oligomeric species and accelerates the formation of not cytotoxic fibrils [108]. This seems
mainly due to the fact that dimerization of αSN increases surface hydrophobicity, as
suggested by the observed increased affinity of ANS [108].
Since the intrinsically disordered nature of αSN manifests in its extraordinary capabil-
ity to modulate its conformation in relation to the environment, changing chemico-physical
parameters leads to changes in protein structure and, in the light of what said, strongly
influences the αSN aggregation propensity. In this context, in addition to temperature
and pH above mentioned, it is important also to consider the dielectric constant of the
solution or solvation properties of αSN. In this regard, fluorinated alcohols, such as
trifluoroethanol (TFE), are able to modulate this two parameters and, as a consequence,
the fibrillation process of αSN.
Furthermore, interaction with membranes has to be taken into account. It is well
established that αSN interaction with membranes results in protein folding with the
formation of α-helices. The number and kind of helices seems to be regulated by
lipid/protein ratio and membranes curvature radius [95]. For example, αSN shows an
extended α11/3-helix (11 residues per 3 full turns) upon binding to unilamellar vesicles,
both small (SUVs) and large (LUVs), or to SDS micelles at a lipid-to-protein ratio
of 2000. Lowering this ratio to 400 leads to the population of a conformational state
containing two canonical α-helices, coexisting with the other one just mentioned. In
both cases, however, the the C-terminal region is not involved in the folding, remaining
in its disordered state [95]. Recent evidences report that the N-terminal consisting of
the first 25 residues interacts with membranes in a stronger manner than the remain
residues [153, 154]. Moreover, in 2012 Zigoneanu et al. investigated the affinity of αSN
for lipid vesicles with a composition similar to mitochondrial membranes, suggesting that
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the protein destabilizes the inner membrane [154].
The interaction of aNS with membranes alters the kinetics and pathways of its
aggregation in vitro. Both acceleration and inhibition of αSN aggregation have been
observed in the presence of membranes [155, 156]. A detailed study of α-synuclein
aggregation in the presence of phospholipid membranes found that the structures and
heterogeneity of the aggregates strongly depended on the experimental conditions [157].
Moreover, it has been observed that the interaction of αSN oligomeric species with
membranes results in membrane permeabilization [158, 159], suggesting a possible cause
for oligomer cytotoxicity [160].
Chapter 2
Materials and experimental
methods
Aim of this chapter is to describe the experimental approach employed in the study
of the aggregation process of Aβ(1-40) peptide and αSN, object of this thesis. These
are two intrinsically disordered proteins involved in the neurodegenerative diseases of
Alzheimer and Parkinson, respectively.
Aggregation kinetics were monitored by means of Rayleigh scattering intensity mea-
surements and ThT fluorescence intensity measurements, both acquired as a function of
time. Besides these two techniques, circular dichroism (CD), small angle x-ray scattering
(SAXS), two photon excitation microscopy (2-PhM) and transmission electron microscopy
(TEM) measurements were employed to investigate protein and aggregate secondary
structure, protein global 3D structure and aggregate morphology, respectively. Moreover,
fluorescence recovery after photobleaching (FRAP) measurements were used to measure
the average hydrodynamic radius of oligomeric species binding ThT in solution.
2.1 Experimental techniques
2.1.1 Rayleigh scattering and fluorescence spectroscopy
In this experimental work Rayleigh scattering intensity and ThT fluorescence signal
were simultaneously acquired as a function of time to monitor the aggregation kinetics.
Rayleigh scattering gives qualitative information about the average size of aggregates in
solution; while ThT is a fluorescent dye widely employed to reveal the presence of fibrils
both in in vivo and in vitro. As a consequence, the Rayleigh scattering signal, acquired
as a function of time, gives information about the overall aggregation process, monitoring
the kinetic of supramolecular assembly, independently of the type of aggregates. On the
other hand, ThT fluorescence signal, acquired as a function of time, allows one to monitor
the kinetics of only fibril formation. These two techniques simultaneously acquired allow
one to individuate possible interconnected pathways of aggregation.
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Fluorescence spectroscopy was widely employed also to perform both two photon
excitation fluorescence microscopy measurements, and fluorescence recovery after pho-
tobleaching measurements. ThT was employed in these two techniques as a fluorescent
dye.
The fluorescent dye Thioflavin T
In the literature the use of optically-active probes employed in in vitro experiments
to monitor aggregation kinetics or characterize their products is quite relevant. For
example the fluorescent dye 1-anilinonaphthalene-8-sulfonate (ANS) is largely employed
to monitor amorphous aggregates production, while the absorption properties of the dye
Congo Red or the fluorescence features of dye Thioflavin T (ThT) have been used to
reveal the presence of amyloid fibrils in vitro and in vivo. Moreover, ThT is nowadays
widely employed to monitor in situ fibril formation, under the fundamental hypothesis
that this probe does not influence the aggregation processes. Although in some particular
cases this hypothesis was actually proved [21, 135], the fact that ThT presence does not
alter the amyloid formation pathway appears to be rather assumed than demonstrated.
There is also a renovated attention for this dye because it was found to slow down
aging processes in the model organisms C. Elegans [24]. These unexpected health benefits
seem to be related to ThT capability of suppressing protein-aggregation-associated paral-
ysis in toxic protein models in multiple tissues [24]. It was intriguingly suggested that
the presence of ThT may affect the amount or the size of proteins prone to aggregate [161].
In this work ThT was used to show that, in the employed experimental conditions,
this dye stronlgy influences the aggregation pathways of both Aβ(1-40) and αSN (in
absence of trifluoroethanol alcohol). Also, ThT spectroscopic properties were employed
to monitor in situ fibril formation during Aβ(1-40) aggregation process triggered by
the dye, and during αSN aggregation kinetics in the presence of trifluoroethanol (not
influenced by the dye).
Here the main structural and spectroscopic characteristics and binding modes to
fibrils of ThT are briefly presented. For a proper description of ThT structural and
optical features and for deeply reviewing this subject, it is suggested to refer to a more
specialized work carried out in the biophysics research group in Palermo [162].
The benzothiazole dye Thioflavin T is an organic molecule, soluble in aqueous solvents,
positively charged in solutions at a pH in the range 2-7. Its structure can be split in
three rather rigid fragments: the benzothiazole group (I), the benzene ring (II) and
the dimethylamino group (III) [163] (Fig. 2.1). In water the dye is characterized by an
absorption band centered around 412 nm. As it is well-assessed, the fluorescence signal of
ThT in aqueous solution is almost vanishing for the presence of highly efficient internal
non-radiative channels, whereas the fluorescence intensity shows a dramatic increase in
the presence of amyloid fibrils both in vivo and in vitro [21, 164–166]. To explain the
enhanced quantum yield in the presence of fibrils in 2003 Voropai et al. and in 2008
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Figure 2.1: Schematic representation of Thioflavin T structure. Three ThT fragments are
shown: benzthiazole ring (I), benzene ring (II), and dimethylamino group (III). Adapted from
the original paper [163].
Stsiapura and coworkers formulated the model of molecular rotor [167]. Starting from
this model Stsiapura et al. performed quantum-chemical calculations of ThT in the
ground and excited singlet states [167]. On the basis of the obtained results, the authors
concluded that the angle ϕ of a ThT molecule in its ground state assumes a value of
about 37◦. The arrival of electromagnetic radiation on a ThT molecule induces the
transition to a locally excited (LE) state, characterized by the same value for the angle
ϕ (∼ 37◦). From this state the reverse transition can take place trough a direct radiative
channel, if the molecule is locked in the initial conformation. On the other hand, if it
is not locked, the transition through a non-radiative channel is more probable to occur.
This consists in a torsional relaxation of LE toward a state characterized by a value of
90◦ for the angle ϕ, followed by a not radiative deactivation to the ground state. On the
basis of this model, binding to fibrils locks ThT molecules preventing rotation.
The mechanism by which ThT recognizes and binds fibrils, amyloid plaques in
diseased tissues or other β-rich self-assembled peptides has been matter of debate in
the last years [166, 168–171]. The main proposed models involve the presence of ThT
micelles [168], formation of ThT dimers [169], or highly directional monomer binding
into β-sheet structured cavities with ThT long axis parallel to the elongation axis of
the fibrils [166]. However, this last model was recently confirmed by experimental and
theoretical works, and it is the most accepted one [172–174].
Fluorescence microscopy
Fluorescence microscopy employs the intrinsic or extrinsic fluorescent properties of
samples to acquire microscopy measurements. This technique allows one to enhance
the contrast of biological sample, with respect to the case of simple optical microscopy.
Moreover, by means of different fluorescent dyes, emitting in different spectral regions
and specifically binding to different regions of the sample, it is possible to selectively
investigate it.
The sample can be excited by means of electromagnetic radiation both in the visible
or infrared region of the electromagnetic spectrum, resulting in one photon or two photon
28 2. Materials and experimental methods
excitations, respectively. In the first case the emitted electromagnetic radiation comes
not only from the focused plan, but also from the adjacent out of focus planes, leading
to blurry imagines. To overcome this drawback, in confocale microscopy, a pinhole is
employed in order to remove the out of focus radiation. In the case of two photon
excitation the incoming beam is able to effectively excites only the focused portion of the
sample, making unnecessary the use of the pinhole. The use of two photon excitation
microscopy is particularly useful when one wants to avoid radiation damage of samples
and/or dyes.
Besides the acquisition of microscopy imagines, fluorescence microscopy can be used
to determinate the average size of particles in solution, under the instrumental resolution,
which is around 200 nm. Shortly, in FRAP measurements a small sample region containing
a fluorescent dye is illuminated with an high intensity laser beam. Its wavelength is
chosen within the dye absorption band, in order to bleach the largest possible number of
dye molecules in this area. Then the fluorescence intensity recovery as a function of time
is acquired. By means of its temporal behaviour it is possible to establish the degree
of homogeneity of the sample (single or multiple exponential growth) and the average
values of the diffusion coefficients. Indeed, after bleaching the fluorescence is recovered
by the diffusion of unbleached molecules inside the pre-bleached area. In this work the
Kapitza model [175] was used to analyse fluorescence recovery data.
2.1.2 Circular dichroism
Consider the two circular polarized components (right and left circularly-polarized
beams) of a beam of linearly polarized light passing through a sample. CD signal is
defined as the difference in absorption of left and right polarized light, and is usually
expressed in term of molecular ellipticity according to the following formula:
[θ] =
4500
pi
ln(10) (εL − εR) (2.1)
where εL and εR are the molecular extinction coefficients for the left and right circularly-
polarized light, respectively. From the Lambert-Beer low, their difference is given by:
εL − εR = 1
LC
log10
(
IR
IL
)
(2.2)
where IR and IL are the intensities of the right and left circularly-polarized transmitted
light beams, respectively.
Circular dichroism (CD) measurements in the Far-UV region (180-240 nm) give
qualitative information about protein secondary structure. The absorption in this region
is due to the peptide bond. On the other hand CD spectra in the region 260-320 nm are due
to aromatic residues absorption and give information on protein tertiary structure [176].
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2.1.3 Small angle x-ray scattering
Small angle x-ray scattering (SAXS) is a powerful method for the structural char-
acterization of biomolecular systems, both ordered and disordered, at a resolution level
of a few nm. It is a complementary technique to the high resolution methods of x-ray
crystallography and NMR, and it has the great advantage of not requiring any particular
type of sample treatment. Indeed, measurements can be carried out on solutions. In
particular, in the case of globular proteins this technique gives information about the
global size and shape of macromolecules in solution, on their states and, during protein
folding, on global conformational changes en rout to the native state. It provides three-
dimensional low-resolution structures by means of ab initio and rigid body modelling,
and allow one to asses the oligomeric state of proteins and protein complexes. SAXS
is also a useful technique for the analysis of flexible systems, among which intrinsically
disordered proteins.
Theoretical background
This section reports a short overview on the SAXS theoretical background. For a
comprehensive treatment of this topic it is suggested to check more appropriate books
(for example see [177]).
Figure 2.2: Schematic representation of the diffraction from a solution containing N particles.
See the text for the description. Adapted from [177].
Consider a nonmagnetic, nonconducting, nonabsorbing medium consisting of a solvent
containing N particles. Indicate with O the center of an inertial reference system, and
with ~Ri the vector radius of the particle i with respect to O. Consider an electric field of
the following form impinging upon this system:
~E0(~r, t) = n̂0E0exp
[
i
(
~k · ~r − ωt
)]
(2.3)
where n̂0 is the versor of the incident electric field, E0 its amplitude, ~k = 2pi/λk̂ the
incident wave vector, λ and ω its wavelength and frequency, respectively (see Fig. 2.2).
The electric field scattered by a particle i, respect to the pole O, measured at a distance
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R much larger than interparticle distances is given by:
~Eis(
~R, t) ∝ n̂sfiE0
R
exp
[
i
(
~k′ · ~R− ωt−∆ϕ
)]
(2.4)
where n̂s is the versor of the scattered electric field, ~k′ is the scattering wave vector, ∆ϕ
the phase difference of the scattered field with respect to O and fi is the scattering length
amplitude [177]. It can be shown that the phase difference is given by:
∆ϕ = ~q · ~Ri (2.5)
where ~q represents the scattering vector and is given by (~k′−~k). The total scattered field
at distance ~R is given by the interference of the fields scattered by the N particles:
~Es(~R, t) ∝ n̂s
N∑
i=1
fiexp
(
−i~q · ~Ri
)
(2.6)
As a consequence the revealed radiation intensity can be written as:
〈I (~q, t)〉 =
〈
~ES (~q, t) ~E
∗
S (~q, t)
〉
∝ (2.7)
∝
〈
N∑
i=1
N∑
j=1
{
fi (~q, t) f
∗
j (~q, t) exp
[
−i~q ·
(
~Ri − ~Rj
)]}〉
= (2.8)
=
〈
N∑
i=1
|fi (~q, t) |2
〉
+
〈 ∑
i,j(i 6=j)
{
fi (~q, t) f
∗
j (~q, t) exp
[
−i~q ·
(
~Ri − ~Rj
)]}〉
(2.9)
In the case of statistically independent particles, which can be approximated by diluted
solutions, the last term in equation 2.9 vanishes. So, if the system is a diluted solution of
N identical particles the expression for the intensity reduces to:
〈I (~q, t)〉 ∝ N 〈|fi (~q, t) |2〉 = N 〈Ip (~q, t)〉 (2.10)
Where 〈Ip (~q, t)〉 is the scattering intensity due to the interference created by atoms within
a single particle. In order to determine this quantity one can repeat an argument similar
to that presented above, substituting the N particles with NA atoms, the scattering length
amplitude with the atomic scattering length amplitude. Indicating with ~rn the vector
radius of the atom n with respect to the pole O, the scattered electric field from this
atom is given by equation 2.4, with the atomic scattering length amplitude, φn, in place
of fi, and ~rn in place of ~Ri in the expression for the difference of phase equation 2.5. As
a consequence, the scattered electric field due to the contributions from all the atoms
inside a particle is given by:
~Eps (~R, t) ∝ n̂s
NA∑
n=1
φnexp (−i~q · ~rn) (2.11)
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Figure 2.3: Schematic representation of the diffraction from a particle consisting of NA atoms.
See the text for the description. Adapted from [177].
From what said the expression 2.10 can be rewritten as:
〈I (~q, t)〉 ∝ N
〈
NA∑
n=1
NA∑
m=1
φnφ
∗
mexp [−i~q · (~rn − ~rm)]
〉
= N
〈|F |2〉 (2.12)
where the quantity:
F =
NA∑
n=1
φnexp (−i~q · ~rn) (2.13)
is called particle structure factor. This depends on the conformation and shape of proteins
in solution, in particular, on their globular or intrinsically disordered conformation. As
explained below, this characteristic allow to easily individuate homogeneous solutions of
globular proteins distinguishing them from solutions containing IDPs.
Globular proteins In the case of solutions containing globular proteins the struc-
ture factor can be evaluated approximating the macromolecules to rigid bodies. This
means that a single protein is considered as a system with fixed interparticle distances.
It can be shown that under this approximation the modulus squared of the structure
factor is given by equation 2.14, known as Debye Equation [177]:
〈|F |2〉 = NA∑
n=1
NA∑
m=1
φnφ
∗
m
sin(qrnm)
qrnm
(2.14)
where qrnm = |~q|| ~rn − ~rm|. In the derivation of 2.14 the probability that ~q and ~rnm form
an angle between ϕ and ϕ+ dϕ has been assumed to be sin(ϕ)dϕ/2.
For qrnm << 1 the expression 2.14 can be developed in series giving:
〈|F |2〉 = NA∑
n=1
NA∑
m=1
φnφ
∗
m
[
1− q
2
6
|~rnm|2 + ...
]
= (2.15)
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=
NA∑
n=1
NA∑
m=1
φnφ
∗
m −
q2
3
NA∑
m=1
φ∗m
NA∑
n=1
φn|~rn|2 + q
2
3
NA∑
m=1
NA∑
n=1
φnφ
∗
m~rn · ~rm + ... (2.16)
Let consider the center of charges, that is the point at the position:
~RO =
∑NA
n=1 φn
~Rn∑NA
n=1 φn
(2.17)
Choosing this point as the pole O, that is putting ~RO = 0, then the third term in 2.16
goes to zero and the expression can be rewritten as:
〈|F |2〉 ≈ | NA∑
n=1
φn|2exp
(
−q
2
3
R20
)
(2.18)
where the quantity:
R20 =
∑NA
n=1 φn|~rn|2∑NA
n=1 φn
(2.19)
is the electronic radius of gyration of particles.
From 2.18 and 2.12 the intensity scattered at q values such that qrnm << 1, for
diluted and homogeneous solutions containing globular proteins, can be approximated to:
I = I0exp
(
−q
2
3
R20
)
(2.20)
known as Guinier approximation [177].
For such a system the plot of ln(I) vs q2 (Guinier Plot) shows a linear behaviour for
q < 1/R0 with a slope equal to
(−R20/3), and an y axis intercept equal to ln(I0), which
can be shown to be proportional to the molecular mass of the particles. This allows one
to calculate a first estimation of the electric radius of gyration, R0, and, after suitable
calibration, of the molecular mass. Moreover, the plot of q2I(q) vs q (Kratky Plot) shows
a bell-shaped behaviour, giving qualitative information on the compactness of proteins
in solution [178].
It should be remember that the Guinier approximation is valid under the hypothesis
of a diluted and homogeneous system containing globular proteins. As a consequence, if
the Guinier plot does not show a linear region at low q values this means that at least
one of the above assumptions is not valid.
Disordered proteins This section briefly takes into account the case of a diluted
and homogeneous solution containing intrinsically disordered proteins. Obviously, in this
case, among the different approximations made above, the one concerning the assumption
of proteins as rigid bodies has to be released. Indeed, in intrinsically disordered proteins
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interparticle distances can not be all considered fixed. In this case the polymer can be
described as a chain of N freely-jointed rigid rods of length b [179].
In order to evaluate the structure factor the distinction between ”good-solvents“ and
”ϑ-solvents“ has to be made. In the first case the polypeptide chain is fully solvated,
excluding the polymer solvation layer from the configuration space of the chain. For this
reason it is said to have excluded volume, resulting in an effective repulsive interaction
between residues. In the second case the excluded volume vanishes and the chain can be
equally well in contact with itself or with the solvent. The probability density for distances
between points on the chain is gaussian and the chain is said to be gaussian [179].
It can been demonstrated that in both cases the Guinier plot does not show any
linear region for low q values. In particular, in the presence of a ϑ-solvent the scattering
intensity can be calculated averaging again the Debye equation 2.14, in order to take
into account all the forms the flexible chain can acquire. The result of this averaging is
given by the following expression [179]:
I = I0
2
x2
[x− 1 + exp (−x)] (2.21)
where x = q2R20. In the presence of a good-solvent this expression is only valid for low q
values while for q > 7/b the scattering intensity is given by:
I ∼ I0
[
pi
qNb
+
4
3b2Nq2
]
(2.22)
Eventually, in both cases (good- and ϑ-solvents) the Kratky plot does not show
any bell-shaped behaviour but a a monotonic increase behaviour followed by a plateau,
instead [75, 179].
2.2 Instrumentation
This section reports the main features of the instrumentation employed in this work.
2.2.1 Instrumentation for the acquisition of Rayleigh scattering and
fluorescence measurements
Rayleigh scattering and fluorescence measurements were acquired simultaneously
using the fluorescence system whose block diagram is reported in Fig. 2.4 (ACTON
Instruments). The excitation light produced by a Xenon Lamp (75 W) comes inside the
excitation spectrograph SpectraPro 2150i (SP-2150i), PI Acton, 150 mm focal length.
This spectrograph allows one to select the excitation wavelength by means of a dual
grating turrets, a grating with a groove linear density of 150 grooves/mm, blazed at
500 nm and the other one with a density of 150 grooves/mm, blazed at 300 nm. Grooves
density and blaze angle determine the spatial resolution on the wavelength selection
(being much precise as bigger is the number of the lines on the grating) and efficiency as
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Figure 2.4: Bock diagram of the fluorescence system (ACTON instruments) used in this thesis.
Adapted from [162]
a function of wavelengths, respectively. The light at the desired wavelength is focalized
on the sample through a micrometer adjustable slit and an optical lens system. This
instrument is able to simultaneously perform absorbance and emission measurements.
Indeed, a feedback system, placed before sample compartment, reveal the intensity of
incident light, while a PMT acquires the transmitted light through another micrometer
adjustable slit. The light emitted from the sample, coming through a third micrometer
adjustable slit, is revealed, in right-angle configuration, and focalized by a lens system in
the emission spectrograph SpectraPro 2300i (SP-2300i), PI Acton, 300 mm focal length,
which disperses it on the CCD camera PIXIS 400 Princeton Instruments, ACTON. The
SP-2300i spectrograph is equipped with three gratings, a 1200 grooves/mm 300 nm blazed
grating, a 300 grooves/mm 500 nm blazed grating and a 150 grooves/mm 300 nm blazed
grating. The CCD camera is thermoelectrically air-cooled down to -75 ◦C to provide a
low value of dark current. Grating and wavelength in excitation and emission can be set
by means of the software SpectraPro and WinSpec32, respectively; while the software
SpectraSense allows one to control the feedback system.
In this work, the excitation and emission grating were chosen to be the one with a
density of 150 g/mm, blazed at 500 nm and the one with a density of 300 g/mm, blazed
at 500 nm, respectively.
In this experimental work the system was only used to acquire emission spectra.
The electron magnetic radiation coming from the sample was acquired as a function
of wavelength. The emitted signal was collected at 90◦ with respect to the excitation
beam in order to minimize sample absorption effects. This configuration allows one to
simultaneously detect the Rayleigh scattering intensity, at the same wavelength of the
excitation beam, and ThT fluorescence, at lower wavelengths.
Since measurements lasted several hours, care was taken to ensure that variation in
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the efficiency of the lamp source will not affect the correctness of the experimental data.
The source signal, acquired each minute from the feedback system, was used to normalize
the emission intensity. However, the diminution of the lamp intensity was less than 3%
in 50 hours of use. Moreover, for samples containing the dye ThT, correction for the
primary and secondary inner filter effects and only for primary filter effects were made
for scattering and fluorescence data, respectively. This was accomplished by means of
the following expression[180]:
Scorr =
Smeas
10
dAbs(435 nm)
l
(2.23)
where Scorr is the corrected scattering signal, Smeas is the measured signal, Abs(435 nm)
is sample absorbance at 435 nm, l is the light path to acquire the absorbance spectrum
(l=1 cm), and d is the effective light path inside the sample during emission spectrum
acquisition.
In this work measurements were performed in standard right-angle geometry on
a 0.5 x 1.0 cm PMMA UV-cuvette (BRAND). As a consequence, d is equal to 3/4 l
for scattering correction and 1/2 l for fluorescence correction. Secondary inner effects
for fluorescence were not taken into account because sample absorption at 490 nm is
negligible.
2.2.2 Instrumentation for the acquisition of two photons excitation
microscopy measurements and fluorescence recovery after photo-
bleaching experiments
Two photons excitation microscopy (2-PM) and fluorescence recovery after photo-
bleaching (FRAP) measurements were carried out using a Leica TCS SP5 confocal laser
scanning microscope (Leica Microsystems, Germany). With this system, images are
acquired scanning a 2-D surface from the left to the right, and from the top to the
bottom.
In order to describe in broad outline the system, in Fig. 2.5 a general picture of
such instrumentation is reported. A description of the main devices shown is given in
the following. The microscope is equipped with three laser line inputs, one for confocal
measurements which allows one to choose between five lasers at different wavelengths in
the visible region (1), and the other two optional, one for an UV laser (3) (not present in
the instrumentation used in this work) and the other one for IR pulsed laser (2). This
last is connected to a Spectra-Physics Mai-Tai Ti:Sa ultra-fast laser, and allows one to
perform 2-ph excitation microscopy measurements. Pulses of the IR laser source are at
a frequency of 80 MHz, with a temporal with <100 fs, average power >650 mW and
peak power >80 kW. Laser wavelength and intensity, and acquisition settings can be
choose by means of the software Leica application suite. In particular, the IR laser source
wavelength can be tuned in the range 780-920 nm. Moreover, in Fig. 2.5, a detector (14),
to acquire measurements very similar to those of the optical transmission microscopy,
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Figure 2.5: Representation of Leica TCS PS5 confocal laser scanning microscope used in the
experimental work of this thesis.
and a Xenon lamp (15), which, through the eyepieces, allows one to quickly select the
region of interest inside the sample, are also shown.
During 2-ph excitation microscopy image acquisition, IR pulses pass trough the
electro-optic modulator (EOM) (5), a software-controlled device which fixes the beam
intensity at the constant value chosen by the user, and the multi function port (MFP)
(9), a type of wavelength filter which reflects IR radiation and transmits visible light.
Then it goes through an optical lens system (10, 11, 12) until reaching the objective (13)
and so the sample. The radiation emitted from the sample is collected by the objective
and goes back through the MFP device (9). Subsequently, it impinges on the Acousto
Optical Beam Splitter (AOBS) (8). This device, software-controlled, allows one to select
the desired spectral range of the emitted radiation, modifying the wavelength window in
the range 400-800 nm. The radiation outcoming from the AOBS device passes through
the pinhole (16) and an optical system (19) and is detected by the photomultipliers
(PMTs) (20-24). The pinhole is a software-controlled slit, essential to perform confocal
measurements. Indeed, it is able to cut down the light emitted from sample coming
from out of focus planes. During 2-ph excitation measurements, since this technique is
intrinsically confocal, this slit is left open (600 µm). The optical system (19) is able to
divide the radiation coming from the sample in several spectral ranges, from one to a
maximum of five, in order to separately acquire them by means of the five PMTs. This
characteristic is really useful since it allows one to stain the sample with dies emitting
in different spectral region, separately and simultaneously acquiring the radiation from
each of them.
The system is equipped with four objectives: 20x air objective NA 0.7, 40x oil
objective NA 1.25, 63x oil objective NA= 1.4 and 100x air objective NA 0.9. For the
measurements acquired in this work the 63x oil objective NA= 1.4 was employed.
This system is also able to perform fluorescence recovery after photobleaching (FRAP)
measurements, by means of the available FRAP wizard of the LEICA control software.
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These measurements allow one to obtain an averaged estimation of the hydrodynamic
radius of populations in solution. This is a really useful technique to employ when the
dimensions of species in solution are under the instrumental resolution (∼200 nm).
To perform FRAP experiments the confocal mode is employed. In this case one of
the five visible laser is chosen. The light path inside the microscope is essentially the
same than for the IR laser beam, width only slightly modifications. The only worth
mentioning difference is the with of the pinhole, which in the confocal mode has to be
reduced so that one can focus on the sample.
2.2.3 Instrumentation for the acquisition of circular dichroism mea-
surements
In this work CD measurements were carried out on a Jasco J-715 spectropolarimeter,
whose block diagram is reported in Fig. 2.6, equipped with a Jasco PCT 348 WI
temperature controller. The light produced by a xenon lamp comes inside a double
monochromator, which produces a monochromated and liner-polarized beam, reducing
stray light. This linearly-polarized light is modulated by the modulator into right and
left circularly-polarized beams, and sent on the sample. If these two circular polarized
components (right and left circularly-polarized beams) are absorbed in different amounts
the sample is said to have circular dichroism.
Figure 2.6: Block diagram of Jasco J-715 spectropolarimeter.
2.2.4 Instrumentation for the acquisition of SAXS measurements
Fig. 2.7 presents a typical setup for SAXS measurements. A collimated monochromatic
x-ray beam is made to strike the sample, a solution of macromolecules placed in a capillary
or cuvette. X-ray beam and the intensity of the scattered beam is measured as a function
of the scattering angle (2θ). In solution, scattering is usually isotropic due to the random
orientation of particles, but SAXS patterns are generally recorded by two-dimensional
detectors, which provide better statistical accuracy of the signal after radial averaging [75].
The scattering patterns are presented as radially averaged one-dimensional curves.
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Figure 2.7: Experimental setup for the acquisition of small angle x-ray scattering measurements.
Adapted from the original paper [75]
This technique is considerably sensitive to beam drift. As a consequence a typical
scattering experiment is carried out measuring the scattered curves from buffer, then
from sample and from buffer again. If the two acquired buffer curves superimpose within
the experimental error, the averaged buffer curve is subtracted from the one of sample.
If this is not the case, that is if the two buffer curves significantly differ, due to beam
drift, measurements have to be repeated.
2.3 Materials and sample preparation
2.3.1 The fluorinated alcohol Trifluoroethanol
Cosolvents, and in particular alcohols, have long being employed to trigger changes
in the conformation of proteins in order to study folding and unfolding kinetics in a
controlled manner. In this work water-TFE mixtures at different alcohol concentrations
were employed to test αSN fibril stability. TFE is known to modulate protein conformation,
changing protein solvent interactions via concentration dependent effects. In particular,
electrostatic interactions and relative stability of hydrogen bonds, can be tuned by varying
TFE concentration [25, 27].
TFE-proteins interaction
2,2,2-Trifluoroethanol (TFE) is a fluorinated alcohol, whose molecular formula is
given by C2H3F3O. It consists in an organic molecule which differ from ethanol for the
replacement of the CH3 group by a CF3 group.
Effects of water-TFE mixtures on the structure of peptides and proteins have been
studied for more than five decades. These mixtures affect the conformation of polypeptide
chains in dependence of the particular amino acid sequences, the cosolvent concentration
and other solution conditions as well as of the structures involved. In particular, both
stabilization and denaturation of proteins were found. As a general rule, in globular
proteins high TFE concentrations lead to the unfolding of the native state and the
stabilization of α-helical secondary structures; while low concentration values facilitate
the formation of β-sheet aggregates [26, 27]. TFE was found to change intra- and
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intermolecular H-bond interactions and, importantly, to induce changes in amyloid fibrils
stability acting as a strong denaturing agent [25, 181].
By means of a large amount of experimental and computational works, performed in
order to investigate the interaction TFE-proteins at molecular level, it has been shown
that a single mechanism which accounts for all the different effects induced by TFE
does not exist [25]. Rather, it seems that TFE acts on different sides: i) it is able to
penetrate the hydrophobic cores of proteins, interacting with hydrophobic groups within
proteins [25]; ii) TFE reinforces hydrogen bonds between carbonyl and amidic groups and
removes water molecules in the proximity of the solute so affecting solvation/hydration
properties of proteins; iii) it changes the properties of bulk water lowering the dielectric
constant. In this regard, in 2003 Munishkina and coworkers showed that, if effects of
single alcohol on αSN conformation can be ascribed to the reduction of the electric
constant value of the solution, in the case of TFE a combination of preferential binding
to the mainchain of αSN and dielectric constant effects have to be taken into account.
This picture is made even more complex by the fact that balancing between the three
different mechanisms depends on the particular system. As a consequence TFE acts as
both a localized structural stabilizer and a global denaturant that provide different, and
potentially competitive, effects depending on the element under investigation [182].
To explain how TFE strengthens intra-chain hydrogen bonds, it has been proposed
that it is likely to bind preferentially to the mainchain carbonyl oxygen group (which is of-
ten able to accept two hydrogen bonds), being a better hydrogen bond donor but a poorer
acceptor compared to water [25]. Since TFE molecules are nine times bigger than water
molecules, this interaction leads to the expulsion of water molecules from the mainchain,
resulting in the reduction of amide group solvent exposure, and, as a consequence, in the
formation of intra-chain hydrogen bounds [25]. This also changes the solvation properties
of proteins. On the other hand, in a recent study it has been postulated that amyloid
formation and non-native helix induction upon addition of cosolvents can be governed by
differential values of dielectric constant [183]. High concentration of cosolvents would
enhance cosolvent-peptide backbone association resulting into dropping off the dielectric
constant by removal of water molecules from vicinity of peptide backbone and mediate
intra-peptide hydrogen bonding to induce helicity [183].
For its features, TFE is generally used to probe structural characteristics of the
enzymes. More in detail, it was used in enzymatic denaturation studies, providing
insights into the folding pathways, enzymatic catalysis and thermal stability [184, 185].
Moreover, it is used to mimic some features of in vivo environment. Indeed, mimicking
the cell environment in in vitro studies is usually accomplished acting on three different
aspects: i) crowding, which provides the typical excluded volume effect experienced by
proteins in living cell, ii) viscosity and iii) solvation/hydration of proteins. It is nowadays
well accepted that TFE can be used to mimic the last two aspects [17]. Furthermore, it
has been reported that water-TFE mixtures at different cosolvent concentrations can be
used to reproduce the effects of membrane on protein-protein electrostatic interactions,
at different distances from membranes [27].
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To conclude, TFE is reported to mimic cell environment accounting for solva-
tion/hydration of proteins in cell, viscosity and dielectric constant effects.
2.3.2 β Amyloid peptide (1-40)
Aβ(1-40) peptide pretreatment
Aβ(1-40) peptide was purchased from Biopeptide (purity>95%) and pretreated before
use. The employed pretreatment consists in a slightly modified Fezoui protocol[186]. The
peptide was dissolved in a 2 mM NaOH aqueous solution (pH 10), sonicated for 30 min
in an ice-water bath, divided in aliquots of 200 µl and freeze-dried before being stored
at -80 ◦C. All phases were accomplished in a cold room. This preliminary procedure
promotes peptide solvation in buffer solution at pH values higher than its isoelectric point
(5.5), reducing the probability that Aβ samples contain aggregation nuclei right after
peptide dissolution. This is essentially due to the fact that dissolving the peptide for
example in a buffer at physiological pH the peptide does not pass through its isoelectric
point, where the solubility in aqueous solution is minimized. Moreover, this treatment
leads to the creation of twin aliquots of about 0.2 mg each, reducing peptide waste.
Aβ(1-40) sample preparation and experimental settings
Commercial ThT was purchased from Sigma Aldrich (purity 65-75%). Recrystallized
ThT was kindly provided by Minna Groenning, Department of Pharmacy, University of
Copenhagen [187].
Immediately before use, the pretreated peptide power (see above) was dissolved in
50 mM sodium phosphate buffer, pH 7.4, with or without ThT, and filtered through a
0.20 µm filter (Sartorius 17761). Dissolution procedure was accomplished in a cold room
in order to avoid seeds formation. Aβ(1-40) and dye concentrations were estimated by
means of absorbance measurements using a molar extinction coefficient of 1390 M−1 cm−1
at 276 nm and 36000 M−1 cm−1 at 412 nm, respectively.
Fluorescence and Rayleigh scattering measurements were carried out simultaneously
during the incubation of the sample at the desired temperature. Measurement were
acquired every 1 minute, in standard right-angle geometry on a 0.5 x 1.0 cm PMMA UV-
cuvette (BRAND), under excitation at 435 nm, using the fluorescence system described
in Section 2.2.1. The temporal window for acquiring the light was set 250 ms. Rayleigh
scattering signal at 90◦ was measured as the maximum of the elastic peaks of excitation
light (435 nm). Data were corrected for possible lamp intensity fluctuations as reported in
Section 2.2.1. All the reported aggregation kinetics were measured in quiescent conditions
and experiments were repeated several times showing an high degree of reproducibility.
For TEM measurements grids were prepared as described by Fodera´ and co-workers[188].
Briefly, 5 µl of the sample were loaded onto copper 400 mesh grids (Agar Scientific,
Stansted, UK) coated with Formvar and carbon film. After 60 s, 10 µl of distilled water
was added and excess water was removed. Subsequently, 10 µl of 2% (w/v) uranyl acetate
(Agar Scientific) was placed on the grid and left for 30 s. Finally, 2x10 µl distilled water
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were added and again excess water removed. The grid was then left to dry. The same
procedure was used for the two samples under investigation. Images were collected using
a CM100 transmission electron microscope operating at an acceleration voltage in the
range of 40-100 kV.
Before to carry out FRAP measurements Aβ(1-40) samples after incubation at 41 ◦C
were cooled down in an ice-water bath. Drops (10 µl) were placed in chambered coverglass
and imaged using the system described in Section 2.2.2. The confocal experiments were
performed using the available FRAP wizard of the LEICA control software.
Far-UV CD measurements were carried out on a sample cell with a path of 0.5 mm.
Spectra were acquired at 25 ◦C using a scan speed of 50 nm/min, data pitch of 0.1 nm,
response of 2 sec, number of accumulations 4. Measurements on thermally treated
samples were carried out just after cooling down in an ice-water bath.
Classical MD simulations were performed in collaboration with the Biophysics Group
of University of Rome-Tor Vergata. People from this research group computationally
analysed the system containing five ThT molecules and one Aβ(1-40) molecule, using
GROMACS package [189].
2.3.3 α-Synuclein
Expression and purification of wild type α-synuclein
Expression and purification of recombinant human wild type αSN were performed at
the laboratories of BioSAXS group, University of Copenhagen, Denmark. The expression
construct was kindly provided by Bioneer, Horsholm, Denmark. The Escherichia coli
plasmid vector p-ET11-a was transfected into an Escherichia coli BL21 (DE 3) cell line for
expression of αSN. Purification of αSN was performed following the protocol developed
by Huang et al. [190]. We slightly modified the procedure and performed an additional
boiling of the lysate and size-exclusion chromatography before and after ion-exchange
chromatography respectively. This is in agreement with previously reported protocols [22].
In short, the periplasmic αSN was released by resuspending cell pellets in an osmotic
shock buffer (30 mM TRIS, 40% sucrose, 2 mM EDTA, pH 7.2). Impurities in the lysate
were precipitated by boiling at 95 ◦C for a maximum of 15 minutes. After filtration,
solution was subsequently loaded onto a HiTrap Q FF column after buffer exchange to
20 mM Tris-HCl pH 8.0. The fractions containing αSN were analyzed by SDS-PAGE and
loaded onto a HiLoadSuperdex 75 column. Fractions solely showing a 14.5 kDa band on
SDS-PAGE were pooled and dialyzed against MQ-water over-night. Lyophilization was
performed prior to storage at -20 ◦C.
αSN sample preparation and experimental settings for fresh prepared αSN
samples investigation and aggregation kinetics
Thioflavin T (ThT) (purity 65-75%) and Trifluoroethanol alcohol (TFE) (purity≥99%)
were purchased from Sigma Aldrich and used without further purification. All the
measurements were performed in aqueous solution: immediately prior to each experiment,
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αSN was dissolved in 50 mM sodium phosphate buffer, pH 7.4, and filtered through
0.20 µm filters (WVR cod. 514-0060). Buffer, TFE and water-ThT solution were
added in suitable volumes in order to obtain 1.2 mg/ml αSN samples in the required
TFE concentration, and containing 20 µM ThT. αSN and dye concentrations were
estimated by means of UV absorbance measurements using a molar extinction coefficient
of 5120 M−1 cm−1 at 280 nm [191] and 36000 M−1 cm−1 at 412 nm [192], respectively.
SAXS experiments on fresh prepared αSN samples were performed at beamline I911-4
at MAX-lab, Lund, Sweden, using a 61-period, 3.5 T, multipole-wiggler operating at a
wavelength of 0.91 A˚. Beam area was of 0.3 x 0.3 mm2. The scattering was registered
on a Pilatus detector in the momentum transfer range of 0.008 < q < 0.45 A˚−1. Sample
exposure was 2 min. Buffers were measured before and after sample exposure, and
averaged before background subtraction. Repeated exposure did not reveal any radiation
damage. The bioXTAS RAW software was used for radial averaging and background
subtraction [193].
For CD measurements in the Far-UV region sample cell path was 0.1 mm. Spectra
were acquired at 25 ◦C using a scan speed of 50 nm/min, data pitch of 0.1 nm, response
of 1 sec, number of accumulations 10.
Fluorescence measurements were carried out every 1 minute, in standard right-angle
geometry on a 0.5 x 1.0 cm PMMA UV-cuvette (BRAND), under excitation at 435 nm
using the fluorescence system described in Section 2.2.1. The temporal window for
acquiring the light was 250 ms. Rayleigh scattering signal at 90◦ was simultaneously
measured as the maximum of the elastic peaks of excitation light. Because of long
time measurements of several hours, data were corrected for lamp intensity variations
as reported in Section 2.2.1. All the reported aggregation kinetics were measured in
quiescent conditions.
For 2-PM measurements samples were stained with ThT right before microscopy
measurements. Aliquots of 10 µl were placed in chambered coverglasses and imaged
at 1024x1024 pixel resolution using the system described in Section 2.2.2. Two-photon
laser excitation wavelength was set at 880 nm. The measurements were performed
using a scanning frequency of 400 Hz, detecting the emitted light in the spectral range
470-600 nm.
αSN sample preparation and experimental settings for fibril stability investi-
gation
αSN samples in 15% TFE v/v, prepared as described above, were incubated for
27 hours at 50 ◦C. After that, samples were cooled down in ice-water bath for 15 min.
Then an aliquot (control sample) was withdrawn and checked by means of 2-PM. The
remaining aggregated sample was spun down at 13000 rpm for 10 min. The supernatant
was removed and investigated by means of CD and 2-PM. These two techniques did
not show neither a detectable CD protein signal nor aggregates within the microscope
resolution. Four identical aliquots were withdrawn from the pellet and diluted 1:10 in
buffer containing suitable TFE concentrations. Four samples (A, B, C, D) at different
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final TFE concentrations were obtained: Sample A at TFE 15% v/v, Sample B at 30%
TFE v/v, Sample C at 60% TFE v/v and Sample D at TFE 1.5% v/v.
CD measurements in the Far-UV region were carried out on sample cells with paths
of 0.1 mm for control sample, 1 mm for supernatant aliquots and 0.5 mm for A, B, C,
D samples. Spectra were acquired using a scan speed of 50 nm/min, data pitch of 0.1
nm, response of 1 sec. Number of accumulations was set to 10 for control, A, B, C, D
samples and 3 for supernatant.
2-PM measurements were curried out as described in the precedent section.
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Experimental Section

Chapter 3
Aβ(1-40) aggregation pathways
controlled by Thioflavin T
In the last two decades several experimental and computational works highlighted
how IDPs conformation are strongly affected by their environment [17, 18]. A change
in pH or addition of co-solvents, metals or co-solutes can reshape the energy landscape
generating deeper minima, so inducing a partially folding, possibly influencing the aggre-
gation processes [26, 88, 94, 103, 104]. In this regard, to take advantage of this aspect for
therapeutic purposes, the possibility of using small molecules to modulate the aggregation
pathway and isolate the occurring species has recently been considered [194–198], in
particular, in order to prevent the formation of cytotoxic species. Indeed, although the
ideal case would be completely inhibiting the aggregation process, it would be significant,
however, to be able to generate new, more likely, aggregation pathways bypassing the
events generating toxic species. Such molecules can delay the fibril formation, stabilize
specific intermediate species or even disrupt the final aggregate [199, 200]. Evidence for
the occurrence of such events has driven an increasing interest towards the understanding
of small molecule-peptide interaction [201, 202]. In particular the role of specific residues
in the peptide-molecule interactions and the possible change in conformation upon inter-
action should be clarified.
In the case of Aβ peptide, it has been established that the hydrophobic core, consisting
of residues 17-21 (Leu17-Val18-Phe19-Phe20-Ala21), plays a key role in the interaction
with small molecules influencing the fibrillation process. Masuda and co-workers reported
that the small molecule Curcumin can affect both Aβ(1-40) and Aβ(1-42) [196] amyloid
fibril formation, with 12th and 17-21st residues of the peptide Aβ(1-42) mainly involved
in the interaction [202]. Moreover, Tjernberg and co-workers showed that the peptide
fragment including residues 16-20 (Lys16-Leu17-Val18-Phe19-Phe20) is the shortest one
displaying a high binding capacity to the full length Aβ(1-40) peptide and the ability of
inhibiting in vitro fibrils formation [203]. Recently, Viet and co-workers demonstrated
that this fragment binds to residues near the N-terminal, Gly9 and His13 [204]. For
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such kind of studies both experiments and simulations have been employed. Specifically,
Molecular Dynamic (MD) has been recently employed in the emerging field of metallo-
proteins and protein-metal interactions [205]. In the case of the Aβ peptide, MD results
have been employed not only to guide experiments, but have also been instrumental in
designing potential Aβ aggregation inhibitors [206].
In this context, this chapter presents the effect of Thioflavin T (ThT), a commonly
used probe for the detection of amyloid-like species, on the Aβ(1-40) conformation,
stability and aggregation and singles out the Aβ(1-40) residues involved in the interaction
with ThT.
3.1 Results and discussion
Fig. 3.1 shows the typical time evolution of Rayleigh scattering intensity measured at
435 nm for 150 µM of Aβ(1-40) in 50 mM sodium phosphate buffer at pH 7.4, incubated
at 41◦C for 46 hours (black line). Green line refers to the measurements on Aβ(1-40) at
the same concentration in the same buffer containing ThT (20 µM) (hereafter Aβ-ThT).
Since Rayleigh scattering gives qualitative information about average size of all aggregates
in solution [207], acquiring its intensity as a function of time allow one to monitor the
growth of all type of aggregates in solution, that is the overall aggregation process. As it
is observed, for the Aβ(1-40) sample the scattering intensity remains constant during
the incubation time. This behaviour indicates that the average size of the particles in
solution remains unchanged at least up to 46 hours. Interestingly, in the presence of ThT
(green line), the scattering signal shows a two-step kinetics: In the first phase it slowly
increases almost linearly, then it undergoes an abrupt growth after about 23 hours (t0).
This behaviour resembles the biphasic kinetics consisting of a lag and a growth phases
which usually indicates nucleated polymerisation mechanisms in Aβ fibrillation [125]. In
panel b) we also report, as control, the corresponding scattering measurement on an Aβ
sample containing Fluorescein at a concentration of 25 µM, instead of ThT. As well as in
the Aβ(1-40) alone sample, changes in the scattering signal are not observed indicating
that the increase of scattering in the presence of ThT is not barely due to the presence
of small organic molecules in solution. Since the acquisition of Thioflavin T fluorescence
signal gives information on the presence/growth of fibrils [20], the time evolution of ThT
fluorescence intensity in the Aβ-ThT sample was acquired, in order to monitor in situ
fibril formation during the aggregation kinetics. In Fig. 3.1-c) the ThT fluorescence
behavior, simultaneously measured with the scattering signal showed in panel a), is
reported. The combination of the two methods can be used to outline different features
of the amyloid growth, and highlight the possible presence of interconnected aggregation
mechanisms. As is observed from Fig. 3.1, in parallel with the first slight increase of
scattering intensity (t< t0) ThT fluorescence shows a first concave growth, followed by
a linear temporal increase after t0. It is worth to note that the first temporal behavior
resembles the kinetics usually observed in seeded nucleated processes, when elongation
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Figure 3.1: (a,b) Rayleigh scattering intensities at 435 nm as a function of time for samples
incubated at 41 ◦C: Black line refers to the sample of Aβ(1-40) at a concentration of 150 µM;
green line corresponds to a similar sample with the addition of 20 µM of ThT; red line corresponds
to a similar sample with the addition of Fluorescein. (c) Fluorescence intensity at 490 nm as a
function of time in the Aβ(1-40) sample containing 20 µM of ThT. The vertical dashed green
lines represent the time of the abrupt increasing of the scattering signal (t0) [187].
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Figure 3.2: (a) Rayleigh scattering intensities at 435 nm as a function of incubation time for
seven representative samples with different ThT concentrations. (b) Enlarged scale of panel a.
For both panels, the curves labeled with stars refer to samples containing recrystallized ThT [187].
from polymer ends is more effective than primary nucleation [134] (see also Section 1.2).
Since light scattering intensity takes into account the average size of all aggregates
in solution, and ThT gives information only on amyloid aggregates, the experimental
observation of a clear non correlation between these two observable has a quite great
importance. Indeed, it indicates that more complex underlyning processes are taking
place in solution.
In Fig.3.2 the time evolution of ThT fluorescence intensity in Aβ(1-40) samples at
different ThT concentrations ([ThT]) in the range 0-66 µM, is reported. To guarantee that
the observed effect of ThT was not due to the presence of impurities in the commercial
ThT (purity of 65-75%), measurements (labeled with stars) were performed also with ThT
purified by a recrystallization procedure where the proton-containing organic impurities
and excess salts were removed. All measured scattering kinetics present the same biphasic
trend (except for data with [ThT]=0): An almost linearly increase in the first hours
and a subsequent abrupt growth after a time t0 which depends on ThT concentration.
Interestingly, as it is pointed out in Fig. 3.3-a), t0 decreases as [ThT] increases. Moreover,
the slope of the first increasing part of scattering data (t<t0) increases linearly with
[ThT] (see Fig. 3.3-b).
Fig.3.4 shows the behaviour of ThT fluorescence as a function of incubation time,
normalized at 3 hours. In all samples the ThT fluorescence intensities grow almost
monotonically as a function of time. In the first part the data perfectly overlap and after
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Figure 3.3: (a) Starting time t0 as a function of ThT concentration. (b) Slope of the lag-phase
(t<t0) of scattering kinetics as a function of ThT concentration. The dashed line represents the
best linear fit to the points. For both panels, stars refer to samples containing recrystallized
ThT [187].
Figure 3.4: ThT fluorescence intensities at 490 nm normalized at 3 h as a function of incubation
time for six representative samples with different ThT concentrations. The vertical dashed lines
correspond to the times t0 when corresponding signals of Fig. 3.2 show a dramatic scattering
increase. Stars refer to samples containing recrystallized ThT [187].
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about five hours the signal increase depends on [ThT].
These results clearly indicate that, in the experimental condition used, the Aβ(1-40)
peptide does not aggregate except when ThT is present in the solution. Upon ThT
addition Rayleigh scattering signal shows a typical biphasic kinetics (lag and growth
phases). The rate of aggregate formation and the lag time, t0, critically depend on ThT
concentration and the progressive increase of ThT fluorescence indicates that structures
which bind this dye are progressively formed. The fact that ThT addition to the Aβ
samples favours its aggregation is confirmed by the experimental observation that the
starting time t0 approaches infinity as [ThT] approaches to zero (see Fig. 3.3-a). That is,
the more the ThT concentration is increased the more the Aβ aggregation speeds up.
It is worthy to note that kinetics profiles and lag times, t0, are repeatable. This
does not clearly evidence the possible absence of a stochastic nucleation mechanism,
especially for the observed concave first growth of ThT fluorescence kinetics resembling
the typical behavior of seeded experiments [134]. Moreover, Rayleigh scattering as a
function of time and ThT fluorescence signal time behaviour do not correlate. The first
observable acquired as a function of time gives information about the overall aggregation
process, while the second one only monitors fibril formation. This allows one to speculate
the presence of different interconnected aggregation pathways, likely characterized by
different intermediate species and different energy barriers[40]. On the basis of concave
ThT fluorescence kinetics reported, and the surprising result of ThT triggered peptide
aggregation process, it is possible to speculate that, already from the early time instants
of kinetics, the formation of ThT-triggered Aβ seeds occurs. In order to investigate the
presence of such species and their morphology, as well as to reveal possible differences
between Aβ samples with and without the addition of the dye TEM measurements were
carried out.
In Fig.3.5, representative transmission electron microscopy (TEM) measurements
are reported for a 150 µM Aβ samples in the presence of 30 µM ThT (panel A, B)
and in the absence (C, D) of ThT before incubation. The two samples were freshly
prepared using identical protocols and then dried on the sample holder. Large quantities
of aggregates are found in the sample where ThT is present (A and B), in particular a
network of tiny aggregates possibly formed by elongated substructures is observed. On
the contrary, samples where ThT is not present show very few aggregates of smaller
size and with lower level of organization (C and D). Obviously, these measurements do
not reflect actual conditions at the first stage of the kinetics, since samples underwent
(identical) drying procedure before imaging, possibly favouring aggregation. However, it
is worth stressing that, since the preparation protocol for the two samples is identical, any
difference between them can only be ascribed to ThT. This means that, Fig.3.5A-D reveal
for Aβ(1-40) an increased tendency to aggregate when ThT is present, even at room
temperature. These measurements indicate that changes induced by the presence of ThT
in solution are effective right after the sample preparation and before thermal treatment.
To gain further insights into the different phases of the process, the morphology of the
species possibly formed before and after thermal incubation at 41◦C and during the
lag phase were investigated by means of imaging techniques. Moreover, the peptide
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Figure 3.5: Panels A, B, C and D: Representative transmission electron microscopy measure-
ments on Aβ(1-40) samples prepared dissolving the peptide in 50 mM sodium phosphate buffer,
pH 7.4, with (A and B) and without (C and D) the addition of 30 µM of ThT. The inset scale
bar in panel D is 2 µm.
secondary structure (with and without ThT, before and after thermal treatment) was
analyzed by means of circular dichroism measurements. Aβ(1-40) samples after 6 hours
of incubation at 41◦ in the presence of ThT were analyzed, as an example.
Fig. 3.6-A reports a representative single colour confocal microscopy measurement.
ThT fluorescence signal (green pixels) is uniformly distributed in the sample (Higher
fluorescence intensity at the border indicates higher local concentration of aggregates
probably due to surface effects) suggesting the presence of small aggregate structures which
bind ThT and whose size is below the instrumental resolution (200 nm). It is possible to
quantify the size of these aggregates using Fluorescence Recovery After Photobleaching
(FRAP) technique. Several FRAP experiments were performed in different areas of
the samples showing a homogeneous presence in solution of small aggregates bound to
ThT. In Fig. 3.6-B a typical profile of fluorescence recovery curve from a circular area
of 10 µm-radius is reported. According to such fluorescence recovery, standard analysis
using the Kapitza model [175] allows one to calculate a diffusion coefficient D = 29 µm2/s.
Similar measurements on different solution areas using bleaching regions (with radius
from 5 to 30 µm) reveal the presence in solution of small aggregates (bound to ThT) with
hydrodynamic radius ranging between 5 nm and 25 nm. In contrast with other standard
techniques (e.g. light scattering or bulk ThT fluorescence), these measurements allow
one to isolate the contribution of the population of molecules which bind to ThT and
contribute to its fluorescence enhancement, determining also their size. These aggregates
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Figure 3.6: Panel A: 512X512 confocal image of the edge of a drop of an Aβ(1-40) sample
prepared dissolving the peptide in 50 mM sodium phosphate buffer, pH 7.4, with the addition of
30 µM of ThT. This sample was incubated at 41 circC and images acquired during the first stage
of the kinetics. Panel B: Typical Fluorescence recovery profile obtained from FRAP experiments
on a circular region of 20 µm radius (ROI-1) on sample in panel A. Panel C: 1024X1024 confocal
image representative of the Aβ(140) in Panel A after 45 hours of incubation.
of fibrillar nature also contribute to the first scattering growth observed in Fig. 3.1-C,
Fig. 3.2 and Fig. 3.8-B and, importantly, they are uniformly distributed in the whole
sample (within instrumental resolution). These structures can either 1) constitute seeds
for further aggregation, 2) represent propagons [42, 194] that may further interact with
non-fluorescent species or 3) be involved in an independent assembly pathway acting
in competition with massive aggregation observed in the second part of the kinetics.
In panel C a representative image of the Aβ-ThT sample incubated for about 45 h is
reported. At this stage, the presence of large fibrils is clearly evident.
Fig. 3.7 shows representative FAR-UV CD spectra for two identical Abeta(1-40)
samples prepared dissolving the peptide in 50 mM sodium phosphate buffer, pH 7.4, with
and without the addition of 30 µM of ThT. Spectra were acquired just after thermal
incubation at 41 circC. Moreover, for comparison, the CD spectrum for the sample
containing ThT after 45 hours of incubation is also reported. No significant differences
are found in FAR-UV CD spectra between the sample containing ThT dye and the one
without. Even after incubation, i.e. when large aggregates are present, the secondary
structure is unvaried. This indicates that most of the peptide secondary structure remains
in the (mostly disordered) initial state, both after ThT addition and thermal treatment.
As detected by fluorescence microscopy and revealed by ThT fluorescence as a function
of time, aggregation kinetics in the presence of ThT leads to the formation of large
aggregates able to bind the dye. However, it is possible to infer that only a small fraction
of the sample is converted into fibrils, leaving a significant part of the molecule with
a nearly unchanged secondary structure. In this case, as also commented by Arosio et
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al. [194], the resolution of CD technique may not allow one for the detection of small
fractions of aggregates/peptides with a modified secondary structure.
Fig. 3.8-A reports the time evolution of Rayleigh scattering growth as a function of
time for three identical 120 µM Aβ (1-40) samples containing 33 µM ThT and incubated
at 37 ◦C (green squares), 41 ◦C (blue squares) and 45 ◦C (red squares). Moreover, in
Fig. 3.8-B shows ThT fluorescence intensity kinetics simultaneously acquired during the
scattering measurements. Data are normalized to the ThT intensity value after 3 hours
of incubation. This is mainly because the evaluation of the absolute values of fluorescence
intensity at the different temperatures is not possible due to the dependence of the
quantum yield on temperature [180]. However, the comparison of the temporal profile of
fluorescence signals during isothermal experiments still provides significant information
about the activation times and growth rates of the occurring processes.
Figure 3.7: Far-UV CD spectra acquired at RT, before thermal incubation, for two Abeta(1-40)
samples prepared dissolving the peptide in 50 mM sodium phosphate buffer, pH 7.4, with and
without the addition of 30 µM of ThT. The spectrum of the sample containing ThT after 45 hours
of thermal incubation at 41 circC is also reported for comparison.
As shown in Fig. 3.1, the scattering signal shows a two-step kinetics with a high
degree of reproducibility: a lag-phase (indicated by dashed lines) in which the signal
slowly increases almost linearly, and a subsequent abrupt growth. The duration of the
lag-phase and the slope of the signal growth in the second phase are critically dependent
on temperature, being the whole process faster at higher temperatures. ThT fluorescence
kinetics in Fig. 3.8-B again shows a first concave growth for t<t0 (before dashed lines)
and a second linear growth. Moreover, the absence of correlation between scattering
and Thioflavin T signals as a function of the time is confirmed also at 37 ◦C and 45 ◦C.
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Figure 3.8: A) Normalized Rayleigh scattering intensity at 435 nm as a function of time for
Aβ(1-40) samples at three different temperatures. The peptide was dissolved in 50 mM sodium
phosphate buffer, pH 7.4, containing 33 µM of ThT, to a final concentration of 115 µM; B)
ThT fluorescence intensity as a function of time simultaneously acquired to Rayleigh scattering.
The fluorescence curves were normalized to the ThT fluorescence intensity value after 3 hours
of incubation in order to compare the temporal profiles. Pink solid line indicates the stretched
exponential fit (see text). Vertical dashed lines correspond to the end of the lag phase (t0) for
the three temperatures.
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The occurrence of the second phase and its slope strongly depend on temperature. The
kinetic ThT profile in the first phase overlaps for 6-7 hours not showing any significant
temperature dependence. It is possible to infer that, in the observed conditions and at
least in the early stages, ThT growth is characterized by the same kinetic profile for
experiments at different temperature, and that only for the sample incubated at 37 ◦C a
plateau is reached before the onset of the second phase, as detected by light scattering
(Fig. 3.8-A).
Concave ThT fluorescence growth was previously observed in Aβ supramolecular
assembly process characterized by a nucleation process occurring in the presence of
seeds [134, 194]. The first concave growth in the kinetics at 37 ◦C can be fitted using a
stretched exponential function y={1 − expb(−β ∗ t)γc} with β ≈ 0.37 sec−1, γ ≈ 0.72
(pink line in Fig. 3.8-B). Stretched exponential function (γ < 1) can be used to provide
a description of phenomena characterised by the presence of a highly heterogeneous
sequence of events or species regulated by a distribution of activation energies. The
stretched exponential function (γ < 1) has been also attributed to systems in which the
growth of larger aggregates takes place primarily by reaction with smaller aggregates [208].
This is the case, for example, of aggregation reactions occurring in pre-seeded samples,
in the particular case in which the process of monomers addition to the polymers ends
prevail over nucleation of new aggregates or fragmentation [134]. In this case the free
monomer concentration decrease with an exponential approach to equilibrium behaviour.
Rayleigh scattering as a function of time and ThT fluorescence signal time behaviour
do not correlate. While the temporal behaviour of Rayleigh scattering gives information
about the overall aggregation process, the second one only monitors fibril formation. As
a consequence, the data shown clearly indicate the presence of at least two aggregation
pathways with different temperature dependence. In particular, the first phase is not
affected by a small increase or decrease in temperature. This could be associated with a
conformational change, driven by specific interactions with ThT, but affecting only a small
fraction of the sample, as suggested by CD experimental results. This conformational
change could be a kind of “ThT-induced partial folding” which acts as rate limiting step
for fibril formation, responsible for the concave ThT fluorescence signal growth.
The analysis previously presented qualitatively indicates the presence of a series of
interconnected mechanisms, including a specific role for ThT, that needs to be clarified.
The initial increase of the ThT signal is independent of the dye concentration and the
temperature. Such enhancement in the fluorescence can potentially be attributed to
changes in the secondary structure of the peptide in the presence of the dye. Indeed,
as already said, it has been widely reported that this dye selectively binds to fibrillar
structures, resulting in the enhancement of its quantum yield.
The dependence of the temporal features of the aggregation kinetics on the peptide
concentration is not obvious. Fig. 3.9 shows the time evolution of Rayleigh scattering
intensity (A) and ThT fluorescence intensity (B), acquired for five Aβ(1-40) samples
with peptide concentration ranging between 25 µM and 150 µM, containing a constant
concentration of ThT (28 µM), during isothermal incubation at 41 ◦C. Fig. 3.10 in
panel (A) and (B) respectively report Rayleigh scattering and Thioflavin T intensity as a
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function of time for three Aβ(1-40) samples incubated at 37 ◦C at a peptide concentrations
of 50 µM, 115 µM and 160 µM.
The duration of the first phase (t0) has a very weak dependence on the peptide
monomer concentration, and no ThT fluorescence growth is observed for samples at
peptide concentration lower than 65 µM during the whole incubation time. Only at
higher peptide concentrations a monotonic concave ThT growth is observed, being larger
at higher peptide concentration. This indicates that there is an interaction of the native
peptide molecules with ThT, resulting in an increased quantum yield of fluorescence since
the very early stages. This last evidence indicates that the protein-solvent-dye balance
of different interactions is also regulated by peptide concentration. It is worthwhile to
note that, in samples where ThT fluorescence intensity growth is not observed, Rayleigh
scattering signal shows anyway a biphasic behavior, with the slope of the first linear
growth not being significant. In samples at higher peptide concentration, the ThT
growth is paralleled by scattering increase, with higher slope at higher concentration.
This is more evident for 150 µM sample when the first 25 hours are considered. This
suggests that the scattering species during this phase are of amyloid-like origin. The
duration of the first phase remains unvaried when protein concentration is increased from
25 µM to 65 µM (i.e. when ThT fluorescence signal growth is not significant) and it
is slightly enhanced when also a ThT fluorescence increase takes place. Specifically, in
samples at peptide concentration of 100 µM and 150 µM the duration of the first phase
increases by about 3 hours with respect to the 25 µM one. This is more evident for
data obtained at 37 ◦C (Fig. 3.10) where the the first phase becomes shorter at lower
concentration of peptide. All the different stages in the observed reaction are regulated
by the rate constants and the number of multiple reacting species occurring at each point
in time and on their relative concentrations and interactions, which can be regulated
in different ways by external factors. This atypical peptide concentration dependence
together with the high repeatability of the observed kinetics (generally observed in the
case of templated processes) indicates a main role of ThT in the aggregation process. In
fact, data in Fig. 3.9 and Fig. 3.10, in combination with the experiments reported in
Fig. 3.2, suggest that peptide-ThT interaction dominates the aggregation process in such
a way that the rate constants of the processes (formation of aggregates binding the ThT
and massive aggregation) depend on the ratio between dye and peptide concentrations.
This indicates that the self-assembly process is modulated by ThT-mediated interactions.
If the process would have been regulated only by pure peptide-peptide interaction, the
aggregation process would have occurred via stochastic nucleation mechanisms (i.e. low
degree of reproducibility [46]) with a strong dependence of the lag phase on the peptide
concentration [36, 44]. This is not observed in our experiments performed in quiescent
conditions. On the contrary, we found that ThT presence in solution clearly alters the
balance between monomer-oligomers-fibrils populations (Fig. 3.5), so that classical scaling
laws for nucleated process are not followed. It is anyway worth noting that the growth
of aggregates able to bind the dye is dependent on the concentration of peptide, and
that, at higher peptide concentration, these structures undergo a further reorganization
leading to the concave profile typical of assembly kinetics regulated by complex nucleation
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Figure 3.9: Panel A: Rayleigh scattering intensity at 435 nm as a function of time for Aβ(1-40)
samples at different peptide concentrations, incubated at 41 ◦C. The peptide was dissolved in
50 mM sodium phosphate buffer, pH 7.4, containing 28 µM of ThT. Panel B: ThT fluorescence
intensity as a function of time simultaneously acquired to Rayleigh scattering in panel A.
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Figure 3.10: Panel A: Rayleigh scattering intensity at 435 nm as a function of time for Aβ(1-40)
samples, incubated at 37 ◦C. The peptide was dissolved in 50 mM sodium phosphate buffer,
pH 7.4, containing 33 µM of ThT. Panel B: ThT fluorescence intensity as a function of time
simultaneously acquired to Rayleigh scattering in panel A.
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mechanisms.
The selected approach gives detailed information on the time evolution of Aβ(1-40)
fibrillation highlighting multiple aggregation pathways and different aggregate species.
Indeed, data reported so far show that Aβ(1-40) aggregation process, in the experimental
conditions investigated, occurs only in the presence of ThT and suggest that the observed
supramolecular association involves at least two different aggregation mechanisms acting
in competition. In the first step, small oligomers, which bind ThT, are formed (provided
that a sufficient amount of ThT is present) via non nucleated polymerization mechanism,
their number increasing as the peptide concentration rises. This process appear to be a
rate limiting step for fibril growth, responsible for the observed concave ThT fluorescence
kinetics. Furthermore, Rayleigh scattering data reveal that the abrupt aggregates growth,
observed in the second part of the process (t> t0), occurs only if the ThT is present in
solution and may occur even in the absence of an increased ThT fluorescence growth.
That is, the formation of small aggregates that bind to ThT is not directly linked to
the occurrence of the massive aggregation at t> t0, but the presence of the dye is a
condicio sine qua non for the activation of the massive aggregation. This indicates that
both processes are triggered by ThT but with different mechanisms and different peptide
concentration-dependences. Moreover, the early formation of ThT-positive species may
act in competition with massive aggregation observed at longer time. This effect is
emphasized at lower temperature (Fig. 3.9, insets). At increasing peptide concentration,
an enhanced population of ThT-positive aggregates is initially formed (Fig. 3.9) probably
having as a direct effect a depletion of the peptide pool. This would in turn determine
the apparent “reverse” dependency on the t0 as a function of the nominal Aβ(1-40)
concentration (Fig. 3.9) observed at 37 ◦C and barely visible at higher temperatures.
Importantly, since such an effect is more evident at lower temperature, we can also
conclude that the two aggregation pathways have different temperature dependencies,
as suggested also by data reported in Fig. 3.8. Regarding the activation of the massive
aggregation, we can infer that ThT presence templates the formation and the enrichment
of a population of a reactive species during the lag-phase [209]. These species may
constitute critical nuclei for further nucleation mechanisms. Alternatively, the “lag time”
may be the time necessary for the activated species to cross a particular solubility limit.
This is supported by the absence of clear peptide concentration dependence for this
process [209], while a strong ThT concentration dependence is observed. This templated
process could resemble the aggregation mechanisms followed by an ensemble of proteins
in the presence of preformed seeds[134, 194].
Given the complex landscape just described, it would be an important piece of
information to obtain insights into the way the dye interacts with a single peptide
triggering the aggregation process. The effect of promoting Aβ(1-40) aggregation has
to be feature of ThT molecules, since the addition of Fluorescein in the solution (an
aromatic molecule with similar molecular weight as ThT) does not trigger any effects
in the first 46 hours (see Fig. 3.1). Interactions between ThT and the peptide seem
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somehow specific and the effect could be related to the symmetry of the molecule and
specific side groups. Hydrophobic and electrostatic interactions between Aβ and ThT
may favour supra-molecular association. In particular, aggregates formation may be due
to the interaction between ThT aromatic rings and non-polar aromatic side chains of
Aβ molecules in solution[164]. It should be noted that the same effect was not found
in amyloid fibril formation from globular proteins [161], [210]. This may be explained
taking into account that Aβ(1-40) is known to have a disordered structure in aqueous
solution[174] so that various conformations are available at the equilibrium for a single
molecule, giving to reactive groups in the chain the possibility of being exposed and to
interact with correspondent groups of the ThT dye. The presence of ThT molecules in
solution may induce conformational changes trapping a specific conformation prone to
supra-molecular assembly, so that this effect could be considered as a possible example
of template-dependent fibrillation [187]. This was shown for other small molecules able
to stabilize different intermediates during the supra-molecular assembly modulating the
fibrillation pathway and determining the final morphology of the aggregates [211–216].
In order to verify the validity of these hypotheses, allowing the investigation at atomistic
level of the mechanisms involved in the interaction between Aβ(1-40) and ThT molecules,
Classical MD simulations of a model system where one Aβ(1-40) peptide is dissolved in
water together with 5 ThT molecules were performed. The rationale for this choice is to
monitor in the behavior of a system where a sufficiently high number of ThT molecules
are in position of interacting with the Aβ(1-40) peptide. It should be noted that, at vari-
ance with the situation simulated in MD, all the experiments previously presented were
performed in conditions where the peptide concentration exceeds that of ThT. However,
it has been emphasized several times that the time behaviour of Rayleigh scattering and
that of ThT fluorescence do not correlate. Since, the first observable gives qualitative
information on the average size of particle in solution, by means of its evolution one can
monitor the overall aggregation process. On the other hand ThT fluorescence temporal
behaviour monitors the formation of only amyloid fibrils. As a consequence multiple
population of Aβ(1-40) molecules, both interacting and non-interacting with ThT, are
seen to exist in solution. As a consequence, it is possible to conclude that the effective
ThT-to-peptide concentration ratio is significantly higher than the nominal one.
Analysis of the effect of the presence of 5 ThT molecules on the peptide structure and
conformation was performed starting from the Aβ(1-40) NMR structure ID:1IYT [217].
Data were compared to the case of Aβ(1-40) peptide in water and in the absence of ThT.
Fig. 3.11A shows the Root Mean Square Displacement (RMSD) as a function of
time including only the peptide backbone atoms of the Aβ(1-40) (green points) and
Aβ(1-40)-ThT (magenta points) systems along the 90 ns of the NpT simulation.
The RMSD is a measure of the configurational modifications [218] of the Aβ(1-40)
structure as a function of the time with respect to a reference one. RMSD(t) is calculated
according to the formula:
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Figure 3.11: A) Aβ(1-40) peptide RMSD(t) as a function of time in the absence (green) and
in the presence (magenta) of ThT molecules along the 90 ns NpT simulation. The cyan area
indicates the initial equilibration time. B) Mobility of Aβ(1-40) residues. Colour code is as before.
Only the last 60 ns of the simulation were used.
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RMSD(t) =
[
1
N
N∑
i=1
|ri (t)− ri (t0) |2
] 1
2
(3.1)
where the coordinates {ri(t), i=1,...,N} in the equation are obtained after minimizing
the expression in square parenthesis over the rigid roto-translations of the current atomic
configuration. The coordinates at the initial time t0 are those of the PDB structure from
which MD simulations have been started. The time behavior of RMSD was computed by
means of the g rms [218] GROMACS’ tool. As can be seen in the region between 30 ns
and 90 ns, the value of RMSD as a function of time is quite stable in the presence of
ThT (magenta) while in the absence of dye molecules (green) it reaches a plateau only in
the last 20 ns (Fig. 3.11A). Moreover, in the first 30 ns (dark cyan area), the two systems
display quite a different approach to equilibrium. In the absence of ThT the RMSD of
the Aβ(1-40) system (green) moves rapidly to a plateau, while the Aβ(1-40)-ThT system
(magenta) gradually approaches it. A comparison of the mobility of the two systems can
be performed in terms of the quantity:
σR =
 1
T
∑
t
1
NR
∑
j
|rj (t)− 〈rj〉 |2
 12 (3.2)
where T is the length of the MD trajectory, { rj(t), j=1,..., NR }, are the positions
of the NR atoms belonging to the residue R and 〈rj〉 represents the average position
of each residue atom along the trajectory. For the computation of this quantity only
the last 60 ns of the simulation were used. The behaviour of σR as a function of the
amino acid residue position for the two systems of interest is displayed in Fig. 3.11B.
The mobility σR is computed using the g rmsf GROMACS routine. The kind of values
taken by σR at the amino acid residue position clearly suggest that the interaction
with ThT imposes constraints, reducing the size of the basin of the peptide accessible
conformations. The 1-16 region does not show any significant mobility differences, while
they are well visible in the 17-38 region. This latter includes the central hydrophobic
cluster 17-Leu-Val-Phe-Phe-Ala-21, which is known to form the core of the minimum
fibril forming sequence [219] that is considered crucial in the aggregation process. Indeed,
planar aromatic interactions involving the two Phe residues were proposed to stabilize
the fibrillar structure and to determine the main structure of the amyloid fibrils [220].
These modifications can be ascribed to the direct interaction of ThT molecules with
specific Aβ(1-40) residues. To verify such hypothesis, Fig. 3.12 reports the measured time
evolution of the distance between the Aβ peptide and each one of the 5 ThT molecules.
In particular, for each ThT molecule, the occurrence of an event where a ThT molecule
approaches a specific Aβ(1-40) residue is reported as a function of the simulation time.
Specifically, a given symbol is drawn in the plot if the center of mass of the n-th ThT
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Figure 3.12: ThT molecules whose center of mass is within 8 A˚ from the Aβ(1-40) back-
bone atoms as a function of simulation time. Data are reported only for the ThT molecules
directly approaching the Aβ(1-40) backbone atoms. (The Aβ(1-40) amino acid sequence is
DAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVV).
molecule is found within 8 A˚ from anyone of the Aβ(1-40) backbone atoms. As shown
in Fig. 3.12 all the five ThT molecules approach the peptide. However, the time of
permanence in the peptide vicinity is quite different. In particular, both ThT nr. 1 and
nr. 4 approach the peptide for a very short time, the former at the end of the simulation
trajectory and the latter in the interval 36-39 ns. ThT molecule nr. 2, instead, comes
close the Aβ(1-40) peptide after about 48 ns and remains in its vicinity until the end of
the simulation. Specifically, it interacts with the residues located at the two extremes of
the fragment 3-26.
It is interesting to note that ThT nr. 2 interacts with an unstructured region by acting
as a ”lock“ that imposes stable hairpin like structure. ThT molecule nr. 3 approaches the
peptide backbone (fragment 5-25) immediately after the simulation starting and remains
in this position for the whole simulation. As is clear from Figure 5, both ThT nr. 2 and
nr. 3 are found to predominantly interact with aromatic residues. ThT nr. 2 interacts
with the peptide in the region 3-6 namely with the sequence Glu-Phe-Arg-His, and 24-27
i.e. Val-Gly-Ser-Asn while ThT nr. 3 interacts very stably along the whole simulation
time with the peptide in regions 10-11 (Tyr-Glu) and 19-21 (Phe-Phe-Ala), forcing these
last residues in a more rigid conformation as shown in Fig. 3.11B. Finally ThT molecule
nr. 5 is found in the vicinity of the peptide (28-40 region) in the last 14 ns close to the
β-sheet structure. It cannot be excluded that this ThT molecule may possibly have a
role in the peptide-peptide interaction. Indeed, the vicinity of the molecule to the β-sheet
structure could favour intermolecular interactions [164] able to block the ThT molecule in
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Figure 3.13: Aβ1-40 DSSP secondary structure as function of simulation time of Aβ(1-40)
peptide in the absence (panel A) and in the presence (panel B) of ThT. The tridimensional
structure of the most representative configuration of each 10 ns simulation are drawn as cartoons.
between two peptide molecules. Secondary structure evolution during the simulation was
monitored using a protocol for the definition of secondary structure of proteins (DSSP)
previously proposed [221] and implemented in GROMACS in the do dssp tool. Fig. 3.13
shows DSSP results ad a function of the simulation time for the Aβ(1-40) peptide both
in the absence (panel A) and in the presence (panel B) of ThT.
Above each DSSP panel, the photograms showing the most representative tridimen-
sional structures of each 10 ns interval are drawn. As can be seen in the Aβ(1-40)-ThT
system, the α-helix structure (blue) is immediately completely lost. At the same time,
β-sheet (red) and turn (yellow) structures in the 28-38 segment, together with a 13-20
segment of 5-helix, appear and remain almost stable for the whole simulation time. We
report in Table 1 the relative content of secondary structure as computed along the final
60 ns.
Coil β-Sheet β-Bridge Bend Turn α-Helix 5-Helix
Aβ 39% 2% 2% 19% 7% 23% 8%
Aβ-ThT 42% 10% 3% 20% 7% 4% 13%
It is worth mentioning here that the influence of ligands on the Aβ(1-40) aggregation
propensity relies on their ability of altering the peptide secondary structure organization.
As an example, ligands able to increase Aβ helix stability are found to reduce fibrils
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Figure 3.14: 3D structure of Aβ(1-40)-ThT system as obtained after 90 ns of equilibration
during the Molecular Dynamic Simulations.
formation, whereas compounds with no effects on secondary structure do not seem to
affect fibril formation [214]. The ThT-peptide interaction is found to ”lock“ the peptide
in a closed chain conformation where the hydrophobic region 28-38 is forced to form a
short β-sheet that may constitute a reactive site for peptides intermolecular interactions.
In fact, looking at Fig. 3.12 and Fig. 3.13, it can be noticed that, when ThT nr. 3 starts
interacting stably with Tyr10 and Phe 19, Aβ(1-40) assumes the β-sheet structure in the
28-38 region and do not lose this structure irrespective of how many other ThT molecules
approach the peptide. The observed differences in Aβ(1-40) fold, together with the close
interaction of ThT nr. 2 and Tht nr. 3 stabilizing an extended β-sheets structure in the
first steps of the simulation represents a proof on the role of the dye in controlling the
secondary structure of the peptide, likely enhancing the overall aggregation propensity of
the peptide ensemble. It is worth noting that, at the end of the simulation, ThT nr. 5
and, for a reduced time, ThT nr. 1 approach the peptide exactly in the β-sheet region,
neither interfering with ThT nr. 3 nor with the stability of the 28-38 secondary structure.
A representative structure of the last 10 ns of simulation is reported in Fig. 3.14, where
three ThT molecules are present.
As it is evident, the ThT nr. 3 templates protein conformation in a way that mimic
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the usual configuration in which Thioflavin T molecules binds amyloidal structures [164].
The two aromatic rings in ThT nr. 3 are packed in between the aromatic rings of
Tyr10 and Phe19. This configuration leads to the critical exposure of other aromatic
residues which may take part in supra-molecular association. Although it is evident
that simulation conditions are far by the experimental ones, MD data can elucidate the
experimentally observed effects of ThT on Aβ(1-40) stability. The ”locked“ ThT-induced
conformation contains a short β-sheet in the hydrophobic region and its subsequent
reduced mobility may indeed change the energetic equilibria of the peptide ensemble.
This could probably lead to favorable stacking interactions also due to the varied spatial
organization of aromatic residues in the presence of the dye as well as to the directionality
and the orientation of new intermolecular bonding. This would be in agreement with
the tendency to aggregation experimentally observed by TEM imaging even at room
temperature (Fig. 3.5) and the ability of ThT in inducing aggregation processes (Fig. 3.1
and Fig. 3.9) otherwise not occurring in its absence (Fig. 3.1). Specifically, it can be
postulated that this “locked” conformation may favour intermolecular interaction both
with “templated” molecules and unstructured monomers giving rise to the two different
aggregation pathways experimentally observed. In particular, a direct interaction of
such ThT-induced conformation could in principle give rise to the formation of the
aggregates binding the dye, while interaction of such state with unstructured monomers
could be at the basis of the observed massive aggregation. Moreover, MD simulation
results are in good agreement with CD measurements. According to the MD data, the
[ThT/Aβ(1− 40)] ratio should be extremely high to observe an overall conversion of
secondary structure in the peptide ensemble (i.e. balance shifted towards Aβ(1-40)-ThT
species). For the occurrence of potential artifacts, such high ratio can not be reproduced
in the presented experiments. As a consequence, in the experimental conditions employed
only a fraction of the Aβ(1-40) sample would be able to interact with ThT, so that the
extent of the expected secondary structure changes cannot be appreciated by CD, being
them within the experimental error.
3.2 Conclusions
As main and quite surprising result, experimental data reported in this chapter
demonstrate that the in vitro Aβ(1-40) aggregation process, in the experimental condition
investigated, is triggered by the fluorescent dye Thioflavin T. Indeed, it has been shown
that this process occurs in the presence of the dye, while do not occurs in identical
samples not containing it. Molecular dynamics simulations presented in this chapter
show that, as a consequence of the ThT presence, a rigid Aβ(1-40) conformation can
occur. This finding and experimental data suggest that the presence of such novel
conformation shifts the balance toward a more aggregation-prone ensemble of molecules.
Aggregation kinetics were monitored by means of Rayleigh scattering and ThT fluorescence
measurements, simultaneously acquired as a function of time. The observation that the
temporal evolutions of these two observables do not correlate leads to the conclusion that
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Figure 3.15: Rayleigh scattering signals as a function of time for two αSN sample at the
concentration of 1.2 mg/ml, incubated at 50 ◦C. The protein was dissolved in 50 mM sodium
phosphate buffer, pH 7.4, with (cyan) and without (pink) the addition of 20 µM of ThT. Rayleigh
scattering remains constant for all the incubation time (about 20 hours) in the case of the sample
non containing the dye, while a biphasic behavior is observed for the sample containing ThT.
The reported kinetics are repeatable. The aggregation process of αSN is triggered by ThT.
the observed in vitro aggregation process is characterized by interconnected molecular
mechanisms. Indeed, while ThT fluorescence as a function of time is related with the
formation of only fibril aggregates, Rayleigh scattering gives qualitative information
about the average size of particles in solution, and so about the overall aggregation
process, whatever the type of aggregates.
More in detail, experimental data show the existence of at least two interconnected
and competing pathways of aggregation, occurring in the presence of ThT, and leading to
the formation of both aggregates binding the ThT and aggregates that do not bind the dye.
Both processes are triggered by ThT but with different mechanisms and different peptide
concentration-dependences. Moreover, the early formation of ThT-positive species may
act in competition with massive aggregation observed at longer time. Further studies are
needed to detect the intermediate steps and aggregated species involved in the observed
supramolecular assembly.
This important result indicates that ThT can act as template to change the Aβ(1-40)
random conformation in a β-aggregated form ready to form amyloid fibrils. This result
could be really significant in the perspective that ThT may favor the conversion of
possible toxic oligomers into less reactive amyloid fibrils, having strong implications in
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the evolution of amyloid related aging processes in living organisms [24]. Moreover, the
finding reported here constitutes a relevant warning for the scientific community, since in
in vitro experiments the spectroscopic properties of this dye are widely used in situ to
monitor fibril formation during protein aggregation processes, under the hypothesis that
it not influence the aggregation processes [20–22]. As a consequence, this work further
brings about the need of developing label-free techniques for a reliable quantitative
investigation of the aggregation process for Aβ(1-40).
To conclude, it is worth to note that Aβ(1-40) peptide in close experimental conditions,
differing from that reported in this study only for the incubation volume, it has been
reported to aggregate trough heterogeneous nucleated mechanisms [125]. In the light of
this observation, the results reported in this chapter give a clear example of how much
strong can be the influence of the environment on IDPs conformation and aggregation
propensity [17, 18]. This consideration is made even more significant by the fact that, in
the same experimental conditions, an analogous effect was also observed for the other
IDP object of this work, α-synulcein (see Fig. 3.15 and Chapter 4). This suggest a
thermodynamic drive toward the stabilization of exposed groups in natively unfolded
proteins by interaction with ThT specific groups. On the other hand ThT has been
reported does not affect the fibrillation process of most globular protein, such as lys, Con
A, BSA, HSA, BLG. This is essentially due to the fact that globular protein in their
native state are characterized by a well folded conformation corresponding to a deep
minimum in the intramolecular energetic landscape (see Fig. 1.1). This results in the
hiding of hydrophobic and aromatic residues from the solvent and, as a general feature,
made globular proteins less sensible to the environment than IDPs.
Chapter 4
α-synuclein aggregation process
modulated by Trifluoroethanol
In the last decades several experimental works have highlighted that IDPs conforma-
tion and aggregation propensity can be strongly influenced by the environment [17, 18],
much more than globular proteins. As reported in Chapter 1, this is essentially due to the
fact that they are characterized by a shallow energetic landscape, being able to explore
different conformational substates. This leads to exposition of aromatic and hydrophobic
residues to the solvent.
The results reported above, establishing that Aβ(1-40) peptide aggregation process, in
the reported experimental conditions, is triggered by interaction with the small molecule
ThT, is a relevant example which well insert in this context. Indeed, it has been suggested
that, as a general rule, if for ordered proteins the first critical step in fibrillogenesis is the
partial unfolding, the earliest stage of fibrillation of IDPs is their partial folding [23]. This
statement has been verified to be true in particular for αSN, whose fibrillation propensity
is negligible in absence of partial folding [222, 223]. As a consequence, in vitro αSN
fibrillation experiments are usually accomplished inducing its partial folding [26, 104], for
example by means of mechanical agitation [22], or changing the pH of the solution [104].
It is well known that trifluoroethanol (TFE) is able to induce modifications in the 3D
conformation of the chain by changing the equilibria in hydrophobic, ionic and hydrogen
bonding interactions. This effect highly depend on TFE concentration. In particular,
TFE-water mixtures are able to modulate αSN conformation on the basis of different TFE
percentages. It has been shown that, at a protein concentration of 0.5 µM, in TFE-water
mixtures, αSN samples at least three different secondary structure conformations in
dependence of TFE concentration: an unfolded conformation, which is approximated
by the 0% v/v TFE point; a partially folded structure populated at moderate TFE
concentrations; and an α-helical conformation, which is approximated by the the 60%
v/v TFE point [26]. The partially folded structure consists in a monomeric, partly
α-helical, conformation, existing in equilibrium with the disordered conformation at
low TFE concentrations, and with the α-helical rich state at high TFE percentages.
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Aggregation kinetics performed in the presence of 15% v/v of TFE, monitored by means
of CD measurements, show that the population of the partially folded structure strongly
correlates with fibril production. In conclusion, the partial helical intermediate is on-
pathway to the TFE induced formation of both the highly helical monomeric conformation
and the fibrillar species [26]. At higher protein concentrations these intermediates are
not observable due to the speeding up of the reaction. In this case the formation of
β-oligomeric species is observed already from the early instants of time [26, 27]. Low
or medium concentrations of TFE, leading to the population of partially structured
states, enhance αSN fibrillation propensity, while the induction of helical rich states
inhibits the aggregation process. It was shown that αSN folding in the presence of TFE
can be attributed to a decrease in the solvent dielectric constant [27]. Such a decrease
resembles the one of water at the water-membrane interface [224]. In this experimental
work TFE-water mixtures at different TFE concentrations were used to monitor their
effect on native αSN, to test αSN fibril stability and investigate different aggregates
morphologies. Direct evidence on how αSN fibril stability strongly depends on TFE
concentration, and how fibrils disaggregation can be obtained by simply reducing TFE
concentration, is reported.
4.1 Results and discussion
4.1.1 αSN aggregation process modulated by TFE
Fig. 4.1 shows the typical circular dichroism spectra for seven identical samples of αSN
at concentration of 1.2 mg/ml. The protein was dissolved in 50 mM sodium phosphate
buffer, pH 7.4, containing different TFE concentrations. In absence of TFE, a shape
typical of disordered structures, with a minimum at about 198 nm is obtained. In the
presence of TFE at concentration higher than 7.5% αSN CD spectrum is characterized
by a minimum at about 216 nm, typical of β-sheet structures, confirming αSN folding
induced by TFE. Analogous results were previously ascribed to TFE-induced αSN
oligomerization [26, 27]. Further increment of the TFE concentration leads αSN to
mainly adopt the expected α-helical structure. These data clearly demonstrate how αSN
secondary structure can be modulated by adding TFE to the solution.
In Fig. 4.2A the time evolution of Rayleigh scattering intensity as a function of time is
reported for three identical samples of αSN at the concentration of 1.2 mg/ml. Measure-
ments were carried out incubating the protein at 50 ◦C in 50 mM sodium phosphate buffer,
pH 7.4 (black), in buffer with the addition of 20 µM of ThT (dark cyan) and in buffer
plus 20 µM of ThT and 15% v/v of TFE (pink). Fig. 4.2B reports the time evolution
of ThT fluorescence intensity as a function of time acquired together the scattering for
the two samples containing the dye. Rayleigh scattering measurements qualitatively give
information about the average size of particles in solution. As consequence, by means
of the temporal behaviour of the Rayleigh scattering signal one can monitor the overall
aggregation process. On the other hand ThT fluorescence signal acquired as a function of
time only reveals the formation of fibrils [21]. From Panel A it is evident that, in absence
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Figure 4.1: Far-UV CD spectra for samples of αSN dissolved in 50 mM sodium phosphate buffer,
pH 7.4, with the addition of TFE at different concentrations, as indicated. All measurements
were performed at RT.
of cosolvent and dye, the scattering intensity remains constant during the incubation
time. This behaviour indicates that the average size of the particles in solution remains
unchanged at least up to 20 hours. This is in line with several in vitro studies reported in
the literature, pointing out that αSN fibril formation in aqueous solution, at physiological
pH, and in quiescent conditions is highly unfavoured [222, 223]. ThT addition to the
solution generates a biphasic scattering curve: the scattering signal remains unchanged
during the first 7 hours of incubation. Then it undergoes a slow, almost linear, increase.
This behaviour resembles that of nucleation processes, characterized by a lag-phase and
a growth-phase. As in the case of Aβ peptide, this suggests a sort of template effect
generated by the dye. However, the acquired ThT fluorescence intensity as a function of
time remains constant during the whole incubation time. This means that ThT addition
does not trigger the formation of fibrils, at least in the experimental conditions employed.
Nevertheless, this is a quite important finding. Indeed, together with the main result
of Chapter 3, it is a clear example of how much strong can be the influence of the
environment on IDPs conformation and aggregation propensity [17, 18].
When TFE is present in solution Rayleigh scattering signal increases from the early
time instants of kinetics. An almost monotonic increase is observed characterized by a
first concave growth followed by a linear increase. Together with it, ThT fluorescence
signal as a function of time presents the same behaviour. No lag phase is observed and
a strong correlation between the time behaviours of ThT fluorescence and scattering
growth exists. Also, it is important to highlight the fact that these kinetics are highly
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Figure 4.2: Panel A Rayleigh scattering as a function of time for three identical αSN samples at
a concentration of 1.2 mg/ml. The protein was dissolved in 50 mM sodium phosphate buffer, pH
7.4, with and without the addition of 20 µM of ThT and 15% v/v of TFE, as indicated; Panel B
ThT fluorescence simultaneously acquired to scattering for samples containing the dye. Samples
were incubated at 50 ◦C.
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reproducible. These observations suggest that supra-molecular assemblies capable of ThT
binding are formed already at the earlier stages of aggregation kinetics and that oligomeric
species are present in solution, forming larger aggregates as a function of time. Indeed,
confirming this hypothesis, the absence of a lag-phase, the initial concave behaviour and
the observed reproducibility remind seeded nucleation processes (see Section 1.2).
These data clearly show that TFE dramatically affects the aggregation process, more
than ThT. Indeed, the biphasic behaviour completely disappears: there is not any lag-
phase and after about 7 hours incubation, in correspondence of the beginning of the
growth-phase observed for the sample without TFE, the scattering signal continues its
linear growth. Moreover, the correlation between the two acquired signals observed in
the presence of TFE leads to the conclusion that in this case all the produced species
are ThT-positive. As a consequence, a complex process with one aggregation pathway
activated by TFE and another activated by ThT can be excluded, at least within the
experimental error. In view of these data, it is possible to conclude that the aggregation
process of αSN in the presence of TFE is not influenced by ThT addition. In this case
ThT plays the only role of a probe, monitoring fibril formation. This is another really
relevant example of how IDPs aggregation processes can be strongly influenced by the
environment. Indeed, it is possible to infer that ThT addition to the protein solution,
not containing TFE, modulates αSN energy landscape in such a way that an amorphous
aggregation pathway is triggered. However, TFE modifies the landscape more strongly,
probably creating minima so deep and barriers so high that the addition of ThT is not
more able to affect αSN aggregation process.
Fig. 4.3 shows small angle x-ray scattering (SAXS) data for two sample of αSN at a
concentration of 1.2 mg/ml. The protein was dissolved in 50 mM sodium phosphate buffer,
pH 7.4, with the addition of 20 µM of ThT and 15% v/v of TFE (pink) and without dye
and alcohol addition (black). These data confirm the induction of oligomerization as a
result of TFE addition, at a concentration of 15% v/v. Panel A shows the scattering
intensity as function of the scattering angle (q = 4pisin(θ)/λ, where λ is the x-ray
wavelength and 2θ is the scattering angle); Panel B shows the relative Kratky plot for
the two samples. From Panel A it is evident that the sample containing TFE presents an
I(0) value higher than that of sample without TFE. This indicates the presence of larger
species in the sample with TFE in comparison with the other one. Moreover, panel B
clearly shows the typical shape of disordered conformation in absence of TFE, while a
bell shape, typical of globular proteins, for the sample containing alcohol [75] (see also
Section 2.1.3). This means that αSN is characterized by a high degree of flexibility when
dissolved in buffer at physiological pH and in absence of co-solvents, while the presence
of TFE forces αSN into a structured conformation.
In summary, data in Fig. 4.1, Fig. 4.2 and Fig. 4.3 show that the aggregation process
originates from oligomeric species having a β-sheet secondary structure and able to
bind the dye. This explanation agrees with the fact that the aggregation process in the
presence of TFE (pink data set in Fig. 4.2) is reproducible.
Fig. 4.4 reports two photon excitation microscopy measurements representative of
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Figure 4.3: Panel A SAXS data for two samples of αSN, dissolved in 50 mM sodium phosphate
buffer, pH 7.4, with and without the addition of 20 µM of ThT and 15% v/v of TFE; Panel B
Kratky plot of A. Measurements were acquired at RT.
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Figure 4.4: Two photon excitation microscopy measurements representative of αSN samples at
a concentration of 1.2 mg/ml. The protein was dissolved in 50 mM sodium phosphate buffer, pH
7.4, containing 20 µM of ThT and 15% v/v of TFE. Samples were incubated at 50 ◦C for about
27 hours. Microscopy measurements were performed right after thermal incubation and cooling
down in a ice-water bath.
αSN aggregates, obtained incubating the samples at 50 ◦C for about 27 hours. The
corresponding Rayleigh scattering and ThT fluorescence measurements, acquired as a
function of time in order to monitor the aggregation kinetics, are shown in Fig. 4.2
(see pink data sets). αSN was dissolved in 50 mM sodium phosphate buffer, pH 7.4,
containing 20 µM of ThT and 15% v/v of TFE. The protein concentration was 1.2 mg/ml.
Since in these measurements the revealed signal is the fluorescence of the dye ThT, one
can conclude that the observed green structures are large fibril clusters surrounded by
“grainy” fibrillar aggregates. Indeed, ThT is usually employed to reveal the in vivo or in
vitro presence of fibrils.
4.1.2 αSN fibrils stability modulated by TFE
In this section results about the stability of the already formed αSN fibrils, as a
function of TFE concentration, are reported. This aspect is really important to take into
account since nowadays fibrils are considered as reservoirs of actual cytotoxic species,
which can be released if fibrils stability is modified [13].
αSN fibrils were produced dissolving the protein in 50 mM sodium phosphate buffer,
pH 7.4, containing 20 µM of ThT and 15% v/v of TFE. Samples were incubated at 50 ◦C
for about 27 hours. Aggregation kinetics were monitored by means of Rayleigh scattering
and ThT fluorescence measurements. The typical scattering and ThT fluorescence signals
as a function of time are reported in Fig. 4.2, panel A and B (pink data sets) (see above
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Figure 4.5: CD spectra for four samples containing αSN aggregates formed in the presence of
15% v/v TFE, diluted in 50 mM sodium phosphate buffer, pH 7.4, with the TFE adjustment
to final concentrations of 15% v/v (A), 30% v/v (B), 60% v/v (C) and 1.5% v/v (D). All the
measurements were acquired at RT.
for the description). After the incubation samples were cooled down, and split in two
parts, one aliquot was left as it was and the other one was treated as shortly described
in the following. The treated aliquot was obtained by spinning down one part of the
sample. Then the pellet was diluted 1:10 in sodium phosphate buffer containing TFE, in
order to obtain samples at different TFE concentrations: A) 15% v/v i.e. unchanged
compared to aggregation conditions, TFE concentration at B) 30% v/v and C) 60% v/v
and D) 1.5% v/v. In Fig. 4.5 the CD spectra of the four samples A, B, C, D are reported.
Samples B and C are characterized by an intensified minimum, at the same position as for
sample A. This suggests a further increase in the relative content of β-strand secondary
elements at increasing TFE concentrations. It is worth nothing that this effect cannot
be ascribed to partially structured conformation induced by TFE on not-aggregated
αSN, (possibly present in the sample). In fact the spectrum referring to sample C (60%
TFE) is in stark contrast to the spectrum recorded in similar experimental conditions for
non thermally treated αSN samples (Fig. 4.1), which shows the typical shape assigned
to α-helix conformation. This is further emphasized by a control CD experiment on
supernatant from spun down samples, which do not show any detectable signal. It can
be hence ruled out that the suspension of the fibrils into increased concentrations of TFE
causes dissolution. Data in Fig. 4.5 indicates that changes obtained by increasing TFE
concentration are related to the increase of order in the β-sheet structures within the
fibrils. On the contrary, upon dilution to 1.5% v/v TFE concentration, CD spectra show
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Figure 4.6: Representative two-photon excitation fluorescence microscopy measurements for
samples containing αSN aggregates diluted in 50 mM sodium phosphate buffer, pH 7.4 and
stained with ThT (green in images), at different TFE concentrations of 15% v/v (A) (panel a)),
30% v/v (B) (panel b)), 60% v/v (C) (panel c)) and 1.5% v/v (D) (panel d)).
a strong modification of the secondary structure of the aggregates, with negligible β-sheet
content in favour of a partially random coil conformation, thus suggesting dissolution of
the fibrils.
With the aim of further investigating and confirming the effect of TFE concentration
on the stability of aggregates, two photon excitation microscopy measurements on the
four samples are reported in Fig. 4.6. Data in panel a) clearly show that large fibril
clusters surrounded by “grainy” aggregates are present in sample at 15% v/v TFE. These
aggregate present the same morphology of that reported in Fig. 4.4, performed on the
sample right after thermal incubation. This last consideration indicates that spinning
down the sample and diluting it in the same buffer do not modify sample characteristics,
at least under the instrument resolution (∼200 nm). Images obtained at 30% or 60% v/v
TFE concentration (panel b) and panel d)), in exactly the same conditions, show similar
morphology but a higher level of supra-molecular organization of fibrils, corroborating
the stabilization of the fibrillar state as suggested by the CD data. Moreover, aggregates
appear brighter, possibly indicating that ThT quantum yield is higher at these TFE
concentrations, i.e. a different arrangement in the local environment around the dye. The
sample at 1.5% v/v TFE concentration shows a reduced and almost vanishing content of
ThT-positive aggregates, in line with CD measurements in Fig. 4.5.
Globally, results indicate that TFE content regulates αSN conformation, affecting
β-sheet content and inducing changes in the aggregate secondary structure, overall
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macroscopic morphology or, alternatively, partial/total dissolution. It is worth noting
that the occurrence of changes in aggregate secondary structure which does not destroy
the supra-molecular assemblies is unlikely, since the decrease of the β-sheet signature in
the CD experiment is coupled with an almost complete disappearance of signals in the
microscopy images.
4.1.3 αSN aggregation process as a function of TFE concentration
In this section some interesting, although preliminary, results are shown, highlighting
that incubation of αSN samples containing different TFE concentrations leads to different
aggregate morphologies. Samples were prepared dissolving the protein in 50 mM sodium
phosphate buffer containing 20 µM of ThT. Moreover, TFE was added to the two
solutions at the concentrations 15% v/v or 1% v/v, respectively. Samples were incubated
at 50 ◦C for about 27 hours. Fig. 4.7 and Fig.4.8 show two-photon excitation microscopy
measurements representative of two αSN aggregates. The measurements were performed
rather after incubation and cooling down of samples in a ice-water bath. Aggregates
Figure 4.7: Two photon excitation microscopy measurements representative of αSN samples at
a concentration of 1.2 mg/ml. The protein was dissolved in 50 mM sodium phosphate buffer, pH
7.4, containing 20 µM of ThT and 15% v/v of TFE. Samples were incubated at 50 ◦C for about
27 hours. Microscopy measurements were performed right after thermal incubation and cooling
down in a ice-water bath.
obtained in the presence of 15% v/v of TFE appear as large “curly” fibril clusters
surrounded by “grainy” aggregates. Incubation at lower TFE concentration leads to
the formation of thinner straight fibrils and fibril clusters. Surprisingly, there are also
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few aggregates in which fibrils are arranged radially with respect to a brilliant area,
usually named precursor. These particular 3D fibril arrangements are usually referred
with the term of spherulites. It is matter of debate if precursors originate from a random
aggregation, with consequent fibril growth outward from the precursor [225] or if growth
of the central part is due to fibril collapse [141]. However, it is generally accepted that
spherulites grow from precursors by sequential addition of protein molecules rather than
from preformed fibrils [11]. Moreover, Fig. 4.8 (top, left) shows a lot of brilliant spherical
aggregates which seams to be spherulite precursors. This hypothesis is confirmed by
two-photon excitation microscopy measurements reported in Fig. 4.9, representative of an
identical sample incubated for about 45 hours. It is evident that after longer incubation
time this kind of aggregates disappear and bigger and thicker spherulites appear, beside
to a large network of thin free fibrils.
Figure 4.8: Two photon excitation microscopy measurements representative of αSN samples at
a concentration of 1.2 mg/ml. The protein was dissolved in 50 mM sodium phosphate buffer, pH
7.4, containing 20 µM of ThT and 1% v/v of TFE. Samples were incubated at 50 ◦C for about
27 hours. Microscopy measurements were performed right after thermal incubation and cooling
down in a ice-water bath.
These, although preliminary, are really interesting results since in vitro formation
of αSN spherulites have never been reported in literature, although a recent study
demonstrated for the first time their existence in cellular environment [143]. Moreover,
these data show how changing TFE concentration leads to the formation of different
supramolecular aggregates. This last being a quite important finding because it highlights
the importance of protein environment in the aggregation processes. At the present
state it is only possible to speculate that the mechanisms through which TFE is able
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to modulate aggregate morphology are driven by electrostatic interactions. Indeed, it
is known from the literature that 3D organization of protein aggregates is driven by
electrostatic forces [80], and that TFE at different concentrations, changing protein-
protein electrostatic interactions, may be able to modulate them. In order to understand
the mechanisms involved and highlight the possible presence of interconnected aggregation
pathways, it could be really important to investigate αSN aggregation kinetics in samples
containing different TFE concentrations. For all these reasons this study is definitely
worth to be deepened.
Figure 4.9: Two photon excitation microscopy measurements representative of αSN samples at
a concentration of 1.2 mg/ml. The protein was dissolved in 50 mM sodium phosphate buffer, pH
7.4, containing 20 µM of ThT and 1% v/v of TFE. Samples were incubated at 50 ◦C for about
45 hours. Microscopy measurements were performed right after thermal incubation and cooling
down in a ice-water bath.
4.2 Conclusions
This chapter draws the attention on αSN aggregation kinetics in relation to the
environment. In line with the literature, data confirm that the initial αSN conformation
and aggregation state is strongly affected by the addition of TFE. This alcohol affects
protein secondary structure and stability on the basis of its concentration [26, 27]. It
acts changing protein solvation properties, but also lowering the dielectric constant of
the solution [25]. As a result, for example, protein-protein electrostatic interactions are
changed.
Importantly, data univocally show that αSN aggregate structure and conformation
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can be tuned by changing the environmental conditions. In particular preformed fib-
rillar structures brought at TFE concentration higher than the ones employed in the
aggregation kinetics, appear to be stabilized and show the tendency in forming larger
macroscopic clusters. Changes in the environment induce an increased ThT quantum
yield and changes towards an enhanced organization at the secondary structure level
with a more pronounced β-sheet content. These conditions thus favour both intra-fibril
structure, via ordering of hydrogen bonding in the β-sheets, and inter-fibril structure, via
increased clustering. Interestingly, when the TFE concentration is reduced, the β-sheet
structures almost completely dissolve and micron-scale fibrils disappear.
Moreover, it is worth to note that αSN aggregation kinetics performed in the presence
of a low TFE concentration lead to the formation of αSN spherulites. This is a quite
surprisingly finding because it has never been reported for αSN in vitro studies. Anyway,
since a recent study demonstrated for the first time their existence in cellular environ-
ment [143], it is worth to deeper investigate this aspect. Further studies are needed
to reveal mechanisms through which TFE is able to modulate the 3D supramolecular
organization of αSN fibrils.
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Conclusions
Results reported in this thesis are aimed at highlighting the effects of environmental
conditions in the modulation of the fundamental interactions, which trigger or modify
aggregation processes and aggregate stability. In particular, aggregation processes of
Aβ(1-40) peptide and the stability of αSN fibrils were analysed. These two intrinsically
disordered proteins were selected since their aggregation is known to be related with the
high impact neurodegenerative diseases AD and PD.
In Chapter 3, the effects of ThT dye on the aggregation kinetics of Aβ(1-40) peptide
were studied. ThT is a small molecule usually employed to reveal in vivo and in vitro
amyloid fibril deposits. Importantly, it is nowadays widely used in situ to monitor
fibril formation in vitro, under the assumption that it does not affect the process itself.
Surprisingly, the results here reported reveal that the presence of ThT in solution triggers
Aβ(1-40) supramolecular assembly in a time scale where aggregation is not observed
in absence of ThT. Results indicate that steric and chemical properties of the ThT
molecule may modulate the peptide conformation. Moreover, the observed increase of
fluorescence of the dye suggests that the interactions with the peptide are similar to the
ones that usually drive the binding of this dye to the already formed amyloid structures.
Experimental observations show that the overall rate of aggregation process increases as
ThT concentration rises and that Rayleigh scattering and ThT fluorescence growth do
not proceed in parallel. This, together with a not obvious dependence of the aggregation
rate on Aβ(1-40) concentration, led to the conclusion that at least two interconnected
pathways of aggregation occur in the presence of ThT, leading to the formation of both
ThT-positive and ThT-negative aggregates. It was shown that ThT-peptide interactions
are able to modify the equilibrium structure of Aβ(1-40) polypeptide chain with respect
to the one in water. In particular, Aβ tridimensional organization is modified together
with secondary structure organization. Moreover, in collaboration with the Biophysics
Group of University of Rome-Tor Vergata and by means of classical molecular dynamics
simulations, three sites of interaction for ThT molecules were identified: i) regions
3-6 namely with the sequence Glu-Phe-Arg-His, and 24-27 i.e. Val-Gly-Ser-Asn; ii)
regions 10-11 (Tyr-Glu) and 19-21 (Phe-Phe-Ala) iii) region 28-40. The interaction with
ThT molecules leads to a rigid partially folded Aβ(1-40) conformation where a short
beta strand is exposed. The results suggest that ThT templated conformation leads to
favourable interactions also due to the changed spatial organization of aromatic residues
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due to the presence of the dye as well as to the directionality and the orientation of new
intermolecular binding. Importantly, it was postulated that the conformation imposed
may favour intermolecular interactions both with“templated” molecules and unstructured
monomers, giving rise to the two different aggregation pathways experimentally observed.
From a general point of view and in light of other results in the literature, which
indicate that small molecules can be used to control aberrant aggregation for the modu-
lation of inter-protein interactions, this result add pieces of information that may have
important medical implications. Indeed, ThT may favour the conversion of possible toxic
Aβ oligomers into less reactive amyloid fibrils.
On the other hand, this result is a fundamental warning for experiments where ThT
is used as a fluorescent probe. The same effect was not observed, in similar experimental
conditions, for globular proteins but it was observed for αSN in this experimental work.
So, it is possible to infer that ThT induces a thermodynamic drive toward the stabilization
of exposed groups in natively unfolded proteins which are expected to populate confor-
mations that are different from each other on all possible length scales. It may mediate a
selection process toward a specific structure whose presence favours the self-assembly
process in these proteins.
In Chapter 4, αSN fibril stability in water-TFE mixtures was analyzed. The study
was performed in collaboration with the BioSAXS group of the University of Copenhagen.
This study is aimed at analyzing the equilibrium of fundamental interactions at the basis
of supramolecular assemblies stability. The idea that the presence of small molecules
may change the aggregation pathways of intrinsically disordered properties by changing
protein-protein and protein-solvent interactions was extended and tested on already
formed aggregates. In particular, αSN stability was analysed in water solution at different
TFE concentrations. TFE is known to modulate protein conformations, changing protein-
solvent interactions via concentration dependent effects. In particular, electrostatic
interactions and relative stability of hydrogen bonds, can be tuned by varying TFE
concentration [25, 27].
Direct evidence was presented on how αSN fibril stability critically depends on TFE
concentration, and how fibril disaggregation can be obtained by simply reducing TFE
concentration i.e. altering the balance of electrostatic interactions and H-bonds.
It has been suggested that water-TFE mixtures at different alcohol concentrations
would qualitatively mimic the effects of the membrane, at different distances, on the
protein-protein electrostatic interactions [27].
Results indicate that, in the reported experimental conditions, making TFE concen-
tration double (or more) induces clustering of αSN fibrils and strengthening of β-sheet
structures. Importantly, a drastic reduction of TFE concentration leads to fibril dis-
solution. This adds a further evidence to the view of the fibrils as reservoirs of toxic
oligomers [13]. Indeed, in the highly dynamic cellular environment fibrils coul experi-
ence different conditions favouring a disassembly process with a consequent release of
oligomeric species, or monomers, from large aggregate clusters. This can result in the
production of potential toxic species able to affect cell integrity and/or in the formation
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of new seeds with higher diffusion coefficients, able to trigger aggregation in different
areas of the brain. For examples, taking in account that TFE-water mixtures have
been proposed to mimic the effect of membrane proximity on αSN, the reported results
may indicate that αSN β-stranded aggregate stability could be strongly modulated,
being either increased or reduced to complete dissolution, by the membrane presence in
the aggregate surroundings. This may have a particular relevance in the PD aetiology,
possibly being relevant in the inter-neuronal diffusion of αSN aggregates [226].
In conclusion, the reported results highlight the importance of the environment in
protein-protein interactions in aggregation processes and fibril stability of intrinsically
disordered proteins. As known, IDPs are characterized by shallow free energy landscapes
with multiple local minima and without global energy minimum typical for the ordered
proteins. This thesis gives two qualitative examples of how, in such free energy landscapes,
minima can be created or made deeper or barriers made higher by the modification of
some chemical or physical environmental factors.
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